Next Article in Journal
Estimation of Critical Fatigue Conditions Based on the Accelerated Fatigue Locati Method by Mean of Net Damage
Next Article in Special Issue
Optimization of Green Sample Preparation for the Determination of Hydroxycinnamic Acids in Multi-Floral Honey Using Response Surface Methodology
Previous Article in Journal
Combustion and Emission Characteristics of a Diesel Engine with a Variable Injection Rate
Previous Article in Special Issue
Application of Natural Edible Coating to Enhance the Shelf Life of Red Fruits and Their Bioactive Content
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Bioactive Compounds, Health Benefits and Food Applications of Artichoke (Cynara scolymus L.) and Artichoke By-Products: A Review

Department of Food Technology, Nutrition and Food Science, Veterinary Faculty, University of Murcia, Regional Campus of International Excellence “Campus Mare Nostrum”, Campus de Espinardo, 30100 Murcia, Spain
*
Author to whom correspondence should be addressed.
Appl. Sci. 2024, 14(11), 4940; https://doi.org/10.3390/app14114940
Submission received: 25 April 2024 / Revised: 31 May 2024 / Accepted: 4 June 2024 / Published: 6 June 2024
(This article belongs to the Special Issue Antioxidant Compounds in Food Processing)

Abstract

:
Cynara scolymus L. is an herbaceous plant originally from the western Mediterranean area, with Italy, Spain and France the main being producers. Both the edible flowering head and the by-products generated during processing (outer bracts, leaves and stem) are characterized by a high content of essential vitamins, minerals and bioactive compounds. In particular, the leaves represent a great source of phenolic acids derived from caffeoylquinic acid or flavonoids such as luteonin and apigenin, while the head and stem contain a high content of soluble and insoluble dietary fiber, especially inulin and pectins. Its high content of bioactive compounds provides artichoke a high antioxidant power due to the modulation effect of the transcription factor Nrf2, which may lead to protection against cardiovascular, hepatic and neurological disorders. The potential use of artichoke as a functional ingredient in the food industry may be promising in terms of improving the nutritional value of products, as well as preventing oxidation and extending the shelf-life of processed foods due to its antimicrobial activity. This review aims to provide an overview of the nutritional qualities of Cynara scolymus L. and its by-products, focusing on the possible health effects and potential applications in food products as a higher-value-added alternative ingredient.

1. Introduction

Cynara cardunculus L. var. scolymus (L.) Fiori or Cynara scolymus L. is a perennial herbaceous plant native to the Mediterranean basin [1]. It belongs to the specie Cynara cardunculus L., which is divided into three subspecies: the wild thistle Cynara cardunculus L. var. sylvestris (Lamk) Fiori; the cultivated thistle Cynara cardunculus var. altilis DC; and the cultivated artichoke Cynara cardunculus var. scolymus L. Fiori. All these varieties belong to the family Asteraceae, the largest existing family with up to 32,913 species and 1911 genera [2].
According to Food and Agriculture Organization Corporate Statistical Database (FAOSTAT), the world production of artichoke was 1,584,513 tonnes in 2022. The European Union accounts for 38.5% of the total world production, with Italy, Spain and France being the main producers [3]. The planting period comprises the months from June to August, and harvesting usually begins in October and ends in May [4]. The artichoke cultivar has a silvery-green appearance and reaches an average height of 1.0–1.5 m [5], although its flower size, appearance and taste differ among the 286 cultivated artichoke genotypes [6]. The edible parts of artichoke are its immature flowers called the capitulum or head [7]. Nevertheless, the flowering head represents only 30–40 g/100 g of its fresh weight, so during the industrial processing of artichoke, about 60–85 g/100 g is discarded as bio-waste and by-products, including its leaves, external bracts and stems [8] (Figure 1).
The therapeutic benefits of artichoke have been known since the ancient Egyptians, Greeks and Romans, who used it as a medicine for the treatment of liver and digestive disorders [9]. The high content of bioactive compounds, such as phenolic acids, flavonoids, anthocyanins, vitamins, inulin and pectins, provide artichoke beneficial effects against a variety of diseases. Numerous studies have found that artichoke present an anti-inflammatory [10], antioxidant [11], antimicrobial [12] and anticarcinogenic [13] effect, as well as an hepato- and cardioprotective action [14]. Moreover, new alternative uses for artichoke bio-wastes have been proposed in order to avoid environmental problems [15]. Artichoke by-products in combination with novel ultrasound- and enzyme-assisted extraction techniques can be a valuable raw material for the manufacturing of value-added products such as food additives, biofuels and agrochemicals [16].
Due to the growing interest in research on the beneficial effects of artichoke, this article aims to review the functional characteristics and health benefits of Cynara scolymus L. for potential applications in the food industry.

2. Nutritional Characteristics

2.1. Aproximate Composition of Artichoke

There is a large variability in nutrients between the different botanical parts of artichoke (head, bracts, leaves and stem) [17,18]. Genetic [19], harvest [20,21], geographic [22] and environmental [23] factors also contribute to this variation. According to Petropoulos et al. [24], artichoke provides 79.73 kcal per 100 g edible portion, with it being considered a low-calorie food due to its high moisture content (approximately 80%) [25,26].
Carbohydrates represent up to 56.62 g/100 g (Table 1) of the dry weight (DW) of artichoke. However, a large part of this constitutes dietary fiber [27] (Section 2.4). Free sugars of a low molecular weight constitute a very small fraction of the total carbohydrates, with sucrose being the most abundant one followed by glucose and fructose [28].
Artichoke head has a protein content of 24.27% DW (Table 1). However, the content of this macronutrient varies in other parts of the artichoke considered as by-products, with it being lower in leaves (8.74%) [27] and bracts (10.35%) [26]. In terms of amino acid composition, essential amino acids represent about 41.04% of the total amino acids, with aromatic amino acids (phenylalanine and proline) being the most abundant followed by the branched amino acids valine and leucine [29]. On the other hand, artichoke is able to fulfil the requirements of all amino acids, with it being a better source of essential amino acids than other vegetables such as carrots, tomatoes, cauliflower, corn or beans [30].
Table 1. Approximate composition of the edible part of artichoke.
Table 1. Approximate composition of the edible part of artichoke.
Nutrient ValueRef.
Energy(kcal/100 g FW)79.73 ± 0.04[24]
Moisture(g/100 g FW)74.54 ± 0.21[27]
Ash(g/100 g DW)6.88 ± 0.14[27]
Proteins(g/100 g DW)24.27 ± 0.12 [26]
Carbohydrates(g/100 g DW) 56.62 ± 1.41 [31]
Fats(g/100 g DW)2.06 ± 0.05[27]
SFAs(%)53.2 ± 0.5[24]
MUFAs(%)2.26 ± 0.05[24]
PUFAs(%)44.5 ± 0.6[24]
DW: dry weight; FW: fresh weight; MUFAs: monounsaturated fatty acids; SFAs: saturated fatty acids; PUFAs: polyunsaturated fatty acids.
The fat content of artichoke is 2–4% DW, with it being lower in the edible flower and higher in the leaves [26]. In addition, artichoke is characterized by a fatty acid profile rich in polyunsaturated fatty acids (PUFAs), representing almost half of the total fatty acids (44.5%). The most abundant unsaturated fatty acid is linoleic acid, with 55.20 mg per 100 g edible portion followed by palmitic acid (34.80 mg/100 g) and α-linolenic acid (20.40 mg/100 g) [32]. Additionally, the edible part of artichoke displays a good PUFAs/SFAs (0.84) and n-6/n-3 (4.64) ratio [24], being in accordance with the parameters recommended by the Food and Agriculture Organization (FAO) [33]. Finally, triterpenes (fardiol and taraxasterol) and sesquiterpenes were found to be the major class of lipophilic components of cultivated cardoon and artichoke leaves [34]. Sesquiterpenes are responsible for up to 80% of the bitter taste of artichoke [35], with cyanoropicrin being the most abundant one [36]. These bioactive compounds have been reported as having anti-inflammatory and anti-hyperlipidemic activity [37].

2.2. Minerals

Artichoke and its by-products represent a good source of minerals necessary for organisms [38]. Compared to the mineral composition of other vegetables reported in the literature, artichoke represents a good source of K and mainly Fe and Zn (Table 2). Deficiency of these minerals can lead to various disorders, such as anemia [39] or neurological [40] and immunological alterations [41]. The concentration of macro- and microelements varies depending on the botanical part of C. scolymus L. [42], but, generally, all parts of artichoke are able to cover the mineral requirements. Also, the genotype and environmental factors play an important role in the mineral content [43]. On the other hand, the Na/K ratio of artichoke (0.1) [43] is one of the lowest among other vegetables such as carrot, cabbage or spinach. Increased values of this parameter are associated with increased blood pressure and cardiovascular disease [44].

2.3. Vitamins

The artichoke head has a high content of vitamins A, B, C, E and K (Table 2). However, the different sections of artichoke are considered vitamin-rich foods, and their content may vary depending on the genotype, storage [53] or harvest [57]. Romo-Hualde et al. [58] observed a variation in the levels of vitamin E and lutein in different varieties of artichoke grown in France, Spain and Italy. Moreover, it has been shown that the content of vitamins C, A, B1, B2, B9 and B12 in artichokes is reduced after cooking [58]. In particular, artichoke has a high vitamin C content, reaching values similar to those of bananas, broccoli or blueberries. This compound contributes to immune defense by supporting various cellular functions of the innate and adaptive immune system. In addition, vitamin C also contributes to epithelial barrier function against pathogens and protects the body from environmental oxidative stress [59].

2.4. Dietary Fiber

The fiber content of artichoke ranges from 31.47 to 85.28 g/100 g DW depending on the plant section (Table 2), with it being more abundant in the floral stem. The total dietary fiber (TDF) of artichoke is proportionally higher than other plants of the same family and of the cruciferous family; its content is also higher than that of other vegetables such as carrot, radish, turnip or asparagus [60]. A large part of its TDF corresponds to insoluble dietary fiber (75%) [49], with cellulose, hemicellulose and lignins being the most abundant compounds, which play an important role in plant growth [61]. Regarding soluble dietary fiber, artichoke has a high content of pectins (20 g/100 g) [16], with galacturonic acid being the most abundant. However, inulin represents a large soluble fiber content of artichoke [62]. Inulin is a fructan-type plant polysaccharide, whose structure is constituted by a variable number of fructose units [63]. This compound is present in all sections of artichoke but is more abundant in the stems (25 g/100 g DW) [52], and its content depends on factors such as storage [64] or food processing [65]. Inulin intake has been shown to improve intestinal flora and stimulate the production of short-chain fatty acids (SCFA), so it is considered a prebiotic [66].

2.5. Phenolic Compounds

Artichoke represents a great source of bioactive compounds such as phenolic compounds. These are secondary metabolites present in plants with a common structure: one or more phenol groups attached to an aromatic or aliphatic structure. These compounds are produced under stressful conditions such as UV radiation, injury and infection. Its main function is to protect against pathogen attack and to intervene in the growth and maturity of the plant [67]. However, the importance of these compounds resides mainly in their function as antioxidants [68].
The most abundant phenolic compounds in artichoke are hydroxycinnamic acids derived from caffeic acid. Most of the caffeic acid present is conjugated with quinic acid, forming caffeoylquinic derivatives. The most relevant are cynarin (1,3-O-dicaffeoylquinic acid), chlorogenic acid (3-O-caffeoylquinic acid), neochlorogenic acid (5-O-caffeoylquinic acid) and 1,5-O-dicaffeoylquinic acid [9]. Although these caffeic acid derivatives are found mainly in artichoke head [20], higher levels of 5-O-caffeoylquinic acid and 1,5-O-dicaffeoylquinic acid have been reported in the leaves and stems [55].
The second most abundant class of natural polyphenols in artichokes are flavonoids, especially flavones. The most abundant are apigenin, luteolin and their respective glycosides and rutosides [69]. Flavonoids in artichoke are mainly concentrated in the leaves and head and are absent in the flower stalk [70]. These compounds have an anti-inflammatory effect [71] as well as the ability to protect cells from oxidative damage. Other important flavonoids in artichoke are anthocyanins, including peonidin, delphinidin and cyanidin and its glycosides (cyanidin-3-glucoside and cyanidin-3,5-diglucoside) [56]. These compounds have been shown to downregulate the production of the inducible nitric oxide synthase (iNOS) isomer, which has a pro-inflammatory effect in the vascular system [72]. In addition, these pigments are responsible for the color of artichoke capitula, which ranges from green to violet [9].
Finally, the amount of these polyphenols varies depending on the harvest [55], genotype [20] and fertilization [73]. Pandino et al. [55] reported a higher amount of phenolic compounds, especially caffeoylquinic acid derivatives, in artichokes harvested between February and April. The processing of the vegetable also plays an important role, as Lim [74] reported a significant increase in the phenolic acids level after boiling artichoke in water. The high water solubility of many phenolic compounds in artichoke can lead to the lixiviation of these compounds, which may be extracted from the plant and become part of the cooking water.

2.6. Enzymes

Several enzymes present in artichoke have been isolated, purified and biochemically characterized. The most important is polyphenol oxidase (EC 1.10.3.1), which, alongside peroxidase (EC 1.11.1.7), is responsible for plant browning [75]. In the presence of oxygen, this copper enzyme hydroxylates monophenols to o-diphenols and oxidizes o-diphenols to o-quinones [76]. Browning is the main problem in the processing of artichoke, as it reduces shelf-life and commercial quality, causing significant economic losses. In addition, many of the phenolic compounds described above are lost by the action of these enzymes, reducing their beneficial effects on health. However, this enzyme can be inactivated if the vegetable is subjected to high temperatures by blanching (75–95 ºC for 1–10 min) [65,77] or immersion in citric or ascorbic acid [78,79], as the chelating compounds present in these compounds sequester the copper from the active center of the enzyme.
Other enzymes present in artichoke are aspartic proteases such as cyprosins A, B and C and cardosins A, B, E, F, G and H [80]. The extraction of these enzymes is of increasing interest as they present a proteolytic activity similar to pepsin [81] and a milk-coagulating activity [82].

3. Health Benefits

3.1. Antioxidant Activity

As described above, C. scolymus L. contains a large number of bioactive compounds, such as vitamin C, caffeic acid derivatives, apigenin, luteolin and various anthocyanins. Apart from performing essential functions in the plant, these compounds, once ingested, can perform protective functions against the generation of reactive oxygen species (ROS) and oxidative damage [68]. Phenolic compounds provide artichoke with a high antioxidant capacity, showing higher ABTS (2,2-azino-bis-3-(ethylbenzothiazoline-6-sulfonic acid)) and FRAP (ferric-ion-reducing antioxidant power) values than other vegetables such as asparagus, cabbage, cucumber, radish, turnip or red beet [83]. This high antioxidant capacity is mainly found in the head and leaves [84], although the rest of the artichoke by-products represent a better source of phenolic compounds than many other foods.
Several studies have observed the inhibition of low-density lipoprotein cholesterol (LDL) oxidation and protection against oxidative stress at an in vitro level in different types of cell lines. Zapolska-Downar et al. [85] (Table 3) observed the protective effects of artichoke leaf extract on endothelial cells and monocytes obtained from umbilical cords, resulting in a reduction in oxidized LDL levels and ROS generation. Carpentieri et al. [86] reported similar results in the application of artichoke stem extracts (1 and 2 mg/mL) in human THP-1 macrophages stimulated with lipopolysaccharide (LPS), obtaining a reduction in ROS and a decrease in proinflammatory cytokines.
The antioxidant effect of artichoke has also been confirmed in in vivo experiments through several meta-analyses [11,125]. Ben Salem et al. [88] investigated the effects of alloxan-induced diabetic rats treated with artichoke leaf extracts daily for 4 weeks, reporting marked changes associated with a protective effect against ROS. Specifically, an increase in catalase (CAT), superoxide dismutase (SOD) and glutathione (GSH) activities was observed in liver and kidney. El-Boshy et al. [89] explored the protective effect of artichoke leaf extract against organic oxidative damage induced by cadmium (Cd) toxicity in rats. After treatment, the artichoke extract significantly improved the immune response and antioxidant system and hepatorenal function, with a significant decrease in malondialdehyde (MDA). Another study in mice with alcohol-induced acute liver injury showed that artichoke leaf ethanol extract could increase SOD and glutathione peroxidase (GPx) levels as well as decrease MDA [90]. There are several mechanisms that explain the antioxidant action of the bioactive compounds present in artichoke. Polyphenols are known to be able to inhibit lipid peroxidation and scavenge ROS due to their metal-ion-chelating effect [126]. The antioxidant capacity of caffeoylquinic acids and flavonoids can also be attributed to their H-donating function due to their specific structural characteristics [127]. However, the modulating effects could be mostly attributed to the interception of free radicals and ROS at the level of critical signaling pathways involving several protein kinases, phosphatases and transcription factors [11]. In particular, antioxidants are able to modulate the nuclear factor E2-related factor 2 (Nrf2) signaling pathway. It has been shown that polyphenols can genetically and epigenetically regulate Nrf2 at the transcriptional, post-transcriptional and translational levels, increasing the cytoplasmic concentration of this protein [128]. The main function of Nrf2 is to transcriptionally activate genes that synthesize enzymes such as NADPH quinone oxidoreductase (NQO1), heme oxygenase (HO-1), CAT and GPx. In addition, Nrf2 regulates inflammatory genes such as transforming growth factor-β (TGF-β) and nuclear factor-kappa (NF-kB) [129]. The sesquiterpene lactone content of artichoke may also regulate antioxidant activity. It has been revealed that cyanoropicrin may inhibit ROS production by upregulating the transcription of genes encoding Nrf2 and NQO1 [130].

3.2. Hepatoprotective Action

The association between the use of different parts of artichoke and a hepatoprotective action against non-alcoholic fatty liver disease (NAFLD) has been supported by numerous studies [131,132,133]. NAFLD is the most common cause of liver disease in the Western world, affecting 25% of the world’s adult population, and it is associated with an increased risk of progression to cirrhosis, hepatocellular carcinoma and cardiovascular disease [134]. NAFLD is characterized by inflammation and liver cell damage that can cause fibrosis. Damaged liver cells secrete enzymes such as aspartate aminotransferase (AST) and alanine aminotransferase (ALT) into the bloodstream, which are considered biomarkers for monitoring disease prognosis [135].
It has been suggested that the antioxidant and anti-inflammatory properties of artichoke could prevent liver toxicity and improve cell membrane integrity, which could be characterized by a reduction in ALT and AST enzyme levels [11]. Phenolic compounds such as caffeic acid and isochlorogenic acid exert hepatoprotective effects by inhibiting oxidative stress through increasing Nrf2 expression, enhancing antioxidant enzyme activities and exerting a protective effect against liver injury [136]. The study by Panahi et al. [99] observed changes in liver size, a reduction in portal vein diameter and a reduction in total bilirubin after consumption of artichoke extract for 8 weeks in adult NAFLD, as well as a reduction in ALT and AST and lipid markers as triglycerides (TG), total cholesterol, high-density lipoprotein cholesterol (HDL-C) and low-density lipoprotein cholesterol (LDL-C). Another study observed a hepatoprotective effect of artichoke in rats after the induction of toxicity with lead (Pb), reporting a reduction in serum levels of ALT, AST, TG, very-low-density lipoprotein cholesterol (VLDL-C) and MDA [96]. A large number of studies have observed changes in the lipid profile associated with changes at the hepatic level produced by artichoke intake [137]. The reduction in LDL, TC and TG induced by artichoke possibly affects liver transaminases, as TG accumulation in hepatocytes is one of the main factors in the development of NAFLD. Luteolin, luteolin-7-O-glucoside and chlorogenic acid have been shown to inhibit 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductase, the enzyme that regulates cholesterol biosynthesis [138]. Therefore, the hepatoprotective effect of artichoke extracts is achieved through various pathways and mechanisms of action.

3.3. Prebiotic and Anti-Inflammatory Effect

The anti-inflammatory and gastrointestinal-disease-modulating effects of artichoke have been extensively studied in recent decades. Numerous studies report the therapeutic properties of artichoke against inflammatory bowel disease (IBF) [139,140,141], a condition characterized by chronic relapses and remissions of inflammation in the gastrointestinal tract. IBD results from immune disorders arising from complex interactions between genetic and environmental factors such as diet, stress, insufficient sleep, alcohol and microbial composition [142].
Holgado et al. [139] measured the prebiotic effect of artichoke by-products after in vitro fermentation by human fecal microbiota, observing an increase in the production of total acetate, propionate and SCFA by the gut microbiota. Another study reported the benefits of artichoke head after short-term colonic fermentation using an in vitro intestinal model; the results showed an increase in total SCFA production and an increase in the bacterial genus Lactobacillus spp. [100]. Vacca et al. [102] observed the effects of gluten-free bread enriched with artichoke leaf extract on Caco-2 cells exposed to LPS after in vitro digestion and colonic fermentations. The extracts produced a decrease in cellular expression of the inflammatory markers TNF-α and IL-1β as well as an increase in the total antioxidant capacity.
Many of the beneficial properties of artichoke are attributed to the large amount of phenolic compounds present in the leaves; however, the head and stems of artichoke are the parts most commonly used to treat digestive disorders. The anti-inflammatory and prebiotic properties are due to the high fiber content of these sections, particularly the presence of inulin and pectins. Inulin has been reported to positively alter the gut microbiota by being fermented in the large intestine and colon by beneficial bacteria such as Bifidobacteria and Lactobacillus, increasing the levels of these species. The functional attributes of these bacteria are known to contribute directly or indirectly to various health benefits, including protection against oxidative stress, pathogenic microbes, hypertension, inflammation and diabetes [143]. Costabile et al. [105] observed that the application of very-long-chain inulin extracted from artichoke in healthy adults for 3 weeks was able to modify the composition of the intestinal microbiota, increasing the levels of Bifidobacteria, Lactobacillus and Bacteroides-Prevotella. As mentioned previously, inulin is also capable of triggering the production of SCFAs (acetate, propionate and butyrate) through bacterial fermentation in the colon [50]. These three compounds present remarkable beneficial health functions; acetate is a substrate for cholesterol and fatty acid synthesis, and propionate is a precursor for the synthesis of glucose in the liver [144]. Butyrate provides an anticancer activity, as it is the main substrate for colonic epithelial cells and plays an important role in cell differentiation and regulation [145]. Pectins present in artichoke also play an important role in its anti-inflammatory effect. One study showed that artichoke pectins reduced the expression of inflammatory markers such as TNF-α, ICAM-I, IL-1β and IL-6 in C57BL/6 mice with colitis [104]. In addition, pectin from artichoke increased the expression of the intestinal barrier genes Occludin and MUC-1. Toll-like receptor (TLR) signaling has been shown to be suppressed by MUC-1, so artichoke pectins increase MUC-1 expression, leading to decreased TLR-4 levels and, thus, a low expression of pro-inflammatory cytokines [146].

3.4. Hypoglycemic Action

Diabetes mellitus (DM) is a complex metabolic disorder characterized by hyperglycemia, a physiologically abnormal condition represented by continued elevated blood glucose levels. Approximately 95% of patients with DM present type 2 diabetes, which is characterized by insulin resistance and β-cell dysfunction [147].
Many studies have evidenced the ability of artichoke to show beneficial effects against this condition due to its hypoglycemic action [148,149]. Alves et al. [107] evaluated the effects of artichoke in alloxan-induced diabetic rats, obtaining positive results with a reduction in plasma glucose levels. Treatment with the extract also significantly prevented serum fructosamine levels and had significantly lower serum TC and TG levels than untreated animals. A study in overweight patients with impaired fasting glucose (IFG) treated with two daily oral doses of artichoke extract for 8 weeks showed similar results, reducing blood glucose and insulin concentrations. Other diabetes markers such as homeostasis model assessment (HOMA) and A1c-derived average glucose (ADAG) were also reduced [108].
The possible mechanisms responsible for the hypoglycemic effects of artichoke are diverse, and several remain unknown. However, it has been evidenced that some bioactive compounds present in artichoke, such as chlorogenic acid, cynarin and luteolin, can decrease glucose uptake through the intestine [150]. In addition, chlorogenic acid is known to be a potent inhibitor of glucose-6-phosphate translocase, and dicaffeoylquinic acid derivatives can modulate alpha-glucosidase activity [109]. Both enzymes are involved in gluconeogenesis and glycogenolysis and therefore in the homeostatic regulation of blood glucose levels. On the other hand, the presence of fiber is known to stabilize the blood glucose level by allowing glucose to be slowly absorbed into the blood [151]. Inulin, the main component of artichoke fiber, can regulate glucagon-like peptide-1, promote β-cell proliferation and reduce β-cell apoptosis [152]. Due to this relationship with the production of SCFA, this compound may also have a role in maintaining the insulin signaling pathway and energy homeostasis [153].

3.5. Cardioprotective Effect

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality, affecting over 523 million people globally, and it is responsible for 45 % of deaths in Europe [154]. The most prevalent CVDs are head failure, hypertension, coronary artery disease, myocardial infarction, cardiomyopathies and peripheral vascular diseases. One of the most important risk factors in the development of CVD is hyperlipidemia. Although definitions vary, it can be defined as concurrent elevations in LDL-C and TG levels [155].
Some studies and meta-analyses have demonstrated the ability of artichoke to reduce hyperlipidemia, blood pressure and hypertension after consumption (Figure 2) [80,150]. Mocelin et al. [113] studied the hypolipidemic and antiatherogenic effects of C. scolymus L. in cholesterol-fed rats and obtained similar effects to simvastatin, a therapeutic drug commonly used to lower TC levels. The treatment reduced serum levels of TC, LDL-C and oxidized-LDL as well as significantly reducing other markers of inflammation (IL-1, IL-6, TNF-α, IFN-γ and C-reactive protein). Another study was able to increase HDL-C levels and decrease the TC/HDL-C ratio after artichoke leaf extract supplementation in adults with low HDL-C and mild hypercholesterolemia [117]. This hypolipidemic activity is mainly due to the presence of various phenolic compounds, such as flavonoids and caffeic acid derivatives, found mainly in artichoke leaves. Chlorogenic acid, a derivative of caffeic acid, is able to induce AMP-activated protein kinase and inhibit sterol regulatory element binding protein, leading to a reduction in cholesterol synthesis. In addition, chlorogenic acid can induce β-oxidation and inhibit malonyl-CoA, which lowers triglyceride levels due to the stimulation of carnitine palmitoyl transferase [156]. As previously mentioned, flavonoids such as luteolin are also able to inhibit the activity of insulin-dependent HMG-CoA reductase, an enzyme involved in cholesterol biosynthesis [157].
It has been found that the inulin present in artichoke heads can modulate the lipid profile by promoting the conversion of cholesterol into bile salts, thereby reducing serum levels of very-low-density lipoproteins and LDL-C [158]. Villanueva-Suarez et al. [115] tested this effect in HFD-fed hamsters treated with a 20% fiber by-product from artichoke, obtaining a decrease in total fat, TC and TG in the liver and an increase in fecal excretion of bile acids as the results.
A study conducted in human coronary smooth muscle cells showed that cynarin and cyanidin present artichoke leaf reduced the activation of the inducible nitric oxide synthase (iNOS) promoter and iNOS protein expression [72]. The main function of this enzyme is the synthesis of nitric oxide (NO), which plays a pro-inflammatory role in the vasculature. On the other hand, artichoke also plays another role in NO regulation, as flavonoids activate the endothelial expression of NO (eNOS), which has a vasoprotective effect, demonstrating a positive synergistic effect in the regulation of this molecule [159].

3.6. Neuroprotective Effect

Neurodegenerative disorders are characterized by a progressive loss of selectively vulnerable populations of neurons [160]. Conditions such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis and frontotemporal lobar dementia are some of the most challenging problems in developed societies with ageing populations [161].
Research in recent years has suggested that the inflammatory response of the central nervous system (CNS) may have an impact in the development of neurodegenerative diseases. In response to neuronal damage, astrocytes and microglial brain cells can release proinflammatory cytokines, such as IL-1, TNF-α and IL-6, into the cerebrospinal fluid [162]. On the other hand, it has been shown that compounds present in artichoke may play an important role in reducing neuroinflammation. A recent study tested the effects of C. scolymus L. on Parkinson’s disease in rats induced with rotenone [123], observing that the compounds present in artichoke leaves can significantly reduce the inflammatory markers IL-1β and IL-6 as well as the apoptotic markers caspase-3 and cytochrome-c. Ibrahim et al. [121] evaluated the neuroprotective effects against aflatoxin in male rats, observing a reduction in free radical production and an increase in antioxidant enzyme activity and also reporting a reduction in markers related to inflammation as AChE and NO [163]. Many polyphenols have been shown to inhibit platelet aggregation, preventing thrombus formation and reducing the risk of cerebral ischemia [164]. In addition, some of these molecules can also reduce hypertension, an important risk factor for cerebral hemorrhage. Polyphenols may reduce inflammation through other pathways such as the control of gene expression regulatory proteins like histones and the transcriptional factor NF-κB [165]. It has also been shown that phenolic compounds can improve serotonin levels in the brain and stimulate the production of brain-derived neurotrophic factor (BDNF), reducing inflammation [166].
One study evaluated the effect of cynarin on 4-aminopyridine-induced glutamate release in rat synaptosomes [167]. This study concludes that cynarin, through the suppression of P/Q-type Ca2+ channels, inhibits PKA activation, thereby decreasing the availability of synaptic vesicles and contributing to the inhibition of glutamate release in the cerebral cortex terminals. This compound present in artichoke could therefore be beneficial against neurodegenerative diseases, as a lot of evidence suggests that glutamatergic dysregulation is an important contributor to the pathology of these diseases [168].

4. Food Industry Application

4.1. Use of Artichoke as a Functional Ingredient

Due to its remarkable antioxidant, anti-inflammatory and prebiotic properties, the use of artichoke in the development of food products may be a key opportunity for the food industry. Several studies have considered the incorporation of different parts of C. scolymus L. in different food products (Table 4) [16]. The valorization of artichoke by-products in the form of extracts has become a promising possibility due to the high inulin content of the stems as well as the antioxidant properties of the leaves as a result of their high content of phenolic compounds.
Bakery products are the most studied food products for the introduction of artichoke. Its high fiber content, high soluble/insoluble fiber ratio and high water-holding capacity make artichoke fiber a great option to incorporate into bread [62]. In particular, several studies have used fiber-rich artichoke by-products in the form of flour to replace wheat, resulting in acceptable sensory characteristics and a bread with a lower volume and higher firmness [170,179,180]. Artichoke has also been used to prepare crackers [171,181], although a negative impact on the overall sensory qualities has been reported. An emerging field of application of artichoke is pasta, where the main objective of its addition is to increase the contribution of the total phenolic content (TPC) and bioactive compounds as well as to improve the shelf-life of the product [169,182]. Finally, its incorporation into pastry products, such as cookies [173] or cakes [172,183], has also been described. These reformulations have as an objective the replacement of both fat and wheat flour.
Meat composition is low in antioxidant compounds and fiber; for this reason, meat products have become a promising field of application for artichoke. Ergezer et al. [175] studied the impact on the antioxidant and shelf-life qualities of beef patties with 500 and 1000 ppm artichoke extract, showing a significant improvement in antioxidant capacity values (TPC and DPPH) as well as a decrease in lipid oxidation (TBARS) at the end of storage. Another study examined the addition of 1% and 3% of artichoke extract in aubergine burgers [176], observing a decrease in the color intensity and firmness of the burger but positively affecting the inhibition of microbial growth. A beneficial effect on meat products such as sausages [174] or mincemeat [184] has also been described, where artichoke application also had a positive impact on the increase in shelf-life.
The addition of artichoke to dairy products has also been documented. The inulin present in artichoke has been used to increase the viability of probiotic bacteria in yogurt [178,185], with satisfactory results being observed in the level of TPC as well as a faster increase in acidity and a shorter incubation time. On the other hand, artichoke has been used as an alternative to calf rennet in cheese production. Artichoke represents a great source of aspartic proteases, also called cardosins/cyprosins or cynarases (cardosin A and cardosin B). Several studies have verified the potential activity of these enzymes as milk coagulants [186,187,188]. Llorente et al. [80] tested the replacement of animal rennet with artichoke head extract in the manufacture of Gouda-type cheeses, obtaining no significant differences in chemical parameters or organoleptic characteristics depending on the coagulant. Therefore, artichoke head extracts may be of interest to replace traditionally used calf rennet.
Finally, artichoke extracts have also been used to prepare healthier beverages [189] or as a substitute for hops in beer [190]. Finally, artichoke extracts have also been used to replace hops in beer or to make healthier beverages. Its use in the form of leaf extract has also been investigated as an effective feed for broilers, increasing the antioxidant capacity of the chicken meat [191] and improving its productive performance [192].

4.2. Antimicrobial Effect

Numerous studies have reported the potential application of artichoke as a functional ingredient in processed foods, showing its high antimicrobial effect. They have demonstrated the ability of artichoke extracts to inhibit the growth of bacteria [12,66,193,194,195] and fungi [196].
Meat and meat products are exposed to many potential hazards in the post-slaughter production process, such as foodborne pathogenic microorganisms and environmental contamination of equipment [184], so the use of artichoke as a meat preservative may be of interest. Both Gram-negative and Gram-positive bacteria can be inhibited by artichoke heads, leaves or stems, especially common pathogens such as Staphylococcus aureus, Pseudomonas aeruginosa, Escherichia coli and Salmonella spp. [114,197]. In addition, there is a growing disapproval of the use of synthetic additives in the food industry. Therefore, the replacement of these additives by artichoke extracts may be of interest in the search for natural alternatives to the management of microbial contamination of perishable foods.
The reason for this potent antimicrobial activity is probably based on the high content of phenolic compounds in the different parts of the artichoke. Polyphenols can lower the intracellular pH, chelate some metals that are necessary for the survival of microorganisms or change the permeability of the bacterial cell membrane and disrupt the transport of substrates [198]. Flavonoids present in artichoke leaves can also interfere with microbial enzyme activity [199], and different caffeoylquinic acid derivatives can disrupt bacterial cell walls [200].

5. Conclusions and Future Trends

Global and European authorities are increasingly concerned with the environmental impact generated by industries, so companies are looking for a greater efficiency and sustainability of agri-food systems. Artichoke and artichoke by-products generated during processing could be an excellent ingredient for other food applications with higher added value, such as the development of additives for processed products or as a substitute for functional ingredients. Its potent antioxidant effect could play an important role in the substitution of synthetic preservatives such as BHA and BHT in perishable meat products. The replacement of traditionally used wheat by artichoke flour in bakery products and pasta could be a promising alternative to enhance the intake of dietary fiber in the diet, contributing to digestive and anti-inflammatory health. Also, its high protein content as well as its good amino acid composition, especially in branched and aromatic amino acids, could be a good choice as an added protein extract in food products. Moreover, as consumers are increasingly interested in less-processed and healthy products, artichoke and its by-products could play a dual role in their incorporation into other food products, contributing to an improvement in the circular economy and providing beneficial effects on hepatic, cardiovascular and neurological health.
However, although the health benefits of artichoke are widely recognized through in vitro and in vivo studies, the existing literature on its application in food is limited. Additional research is needed to properly mask the bitter taste and color provided by artichoke, as a decrease in overall acceptability has been seen in crackers, meats and yogurt. In addition, there are few studies evaluating the stability of certain compounds present in artichoke as well as their most appropriate extraction through novel techniques such as solvent-mediated or ultrasound-assisted extraction. These aspects are key to achieving the optimal way to incorporate artichoke extracts in food products.
As a conclusion, C. scolymus L. represents an excellent food in terms of its key contents of bioactive compounds for the maintenance of beneficial health functions. For this reason, it is necessary to take advantage of the considerable potential of artichoke as well as the by-products generated by its processing through appropriate agro-industrial valorization.

Author Contributions

Conceptualization, P.A. and G.N.; methodology, P.A.; validation, P.A., J.Q., M.d.l.Á.R., R.P. and G.N.; investigation, P.A.; writing—original draft preparation, P.A.; writing—review and editing, P.A., J.Q., M.d.l.Á.R., R.P. and G.N.; visualization, G.N.; supervision, G.N.; project administration, G.N.; funding acquisition, G.N. All authors have read and agreed to the published version of the manuscript.

Funding

This study forms part of the Agroalnext program and was supported by MCIU with funding from European Union Next GenerationEU (PRTR-C17.I1) and by Comunidad Autónoma de la Región de Murcia—Fundación Séneca.

Conflicts of Interest

The authors declare no conflicts of interest.

References

  1. Gatto, A.; De Paola, D.; Bagnoli, F.; Vendramin, G.G.; Sonnante, G. Population Structure of Cynara cardunculus Complex and the Origin of the Conspecific Crops Artichoke and Cardoon. Ann. Bot. 2013, 112, 855–865. [Google Scholar] [CrossRef]
  2. Meng, D.; Xiaomei, Z.; Wenzhen, K.; Xu, Z. Detecting Useful Genetic Markers and Reconstructing the Phylogeny of an Important Medicinal Resource Plant, Artemisia Selengensis, Based on Chloroplast Genomics. PLoS ONE 2019, 14, e0211340. [Google Scholar] [CrossRef]
  3. FAOSTAT. Available online: https://www.fao.org/faostat/en/#data/QCL (accessed on 7 April 2024).
  4. Grabowska, A.; Caruso, G.; Mehrafarin, A.; Kalisz, A.; Gruszecki, R.; Kunicki, E.; Sękara, A. Application of Modern Agronomic and Biotechnological Strategies to Valorise Worldwide Globe Artichoke (Cynara cardunculus L.) Potential—An Analytical Overview. Ital. J. Agron. 2018, 13, 279–289. [Google Scholar] [CrossRef]
  5. Ciancolini, A.; Alignan, M.; Pagnotta, M.A.; Miquel, J.; Vilarem, G.; Crinò, P. Morphological Characterization, Biomass and Pharmaceutical Compounds in Italian Globe Artichoke Genotypes. Ind. Crops Prod. 2013, 49, 326–333. [Google Scholar] [CrossRef]
  6. García-Martínez, N.; Andreo-Martínez, P.; Almela, L. Characterization of Six Artichoke Cultivars and Their Suitability for Agro-Industrial Processing. J. Food Nutr. Res. 2017, 5, 234–242. [Google Scholar] [CrossRef]
  7. Gostin, A.I.; Waisundara, V.Y. Edible Flowers as Functional Food: A Review on Artichoke (Cynara cardunculus L.). Trends Food Sci. Technol. 2019, 86, 381–391. [Google Scholar] [CrossRef]
  8. Jiménez-moreno, N.; Cimminelli, M.J.; Volpe, F.; Ansó, R.; Esparza, I.; Mármol, I.; Rodríguez-yoldi, M.J.; Ancín-azpilicueta, C. Phenolic Composition of Artichoke Waste and Its Antioxidant Capacity on Differentiated Caco-2 Cells. Nutrients 2019, 11, 1723. [Google Scholar] [CrossRef]
  9. Lattanzio, V.; Kroon, P.A.; Linsalata, V.; Cardinali, A. Globe Artichoke: A Functional Food and Source of Nutraceutical Ingredients. J. Funct. Foods 2009, 1, 131–144. [Google Scholar] [CrossRef]
  10. Rotondo, R.; Cruz, P.S.; Masin, M.; Bürgi, M.; Girardini, J.; García, S.M.; Rodríguez, G.R.; Furlan, R.L.E.; Escalante, A.M. Artichoke Extracts with Potential Application in Chemoprevention and Inflammatory Processes. Braz. J. Pharm. Sci. 2022, 58, e19238. [Google Scholar] [CrossRef]
  11. Salekzamani, S.; Ebrahimi-Mameghani, M.; Rezazadeh, K. The Antioxidant Activity of Artichoke (Cynara scolymus): A Systematic Review and Meta-Analysis of Animal Studies. Phytother. Res. 2019, 33, 55–71. [Google Scholar] [CrossRef]
  12. Shallan, M.A.; Ali, M.A.; Meshrf, W.A.; Marrez, D.A. In Vitro Antimicrobial, Antioxidant and Anticancer Activities of Globe Artichoke (Cynara cardunculus Var. Scolymus L.) Bracts and Receptacles Ethanolic Extract. Biocatal. Agric. Biotechnol. 2020, 29, 101774. [Google Scholar] [CrossRef]
  13. Hassabou, N.F.; Farag, A.F. Anticancer Effects Induced by Artichoke Extract in Oral Squamous Carcinoma Cell Lines. J. Egypt. Natl. Cancer Inst. 2020, 32, 17. [Google Scholar] [CrossRef]
  14. El Sayed, A.M.; Hussein, R.; Motaal, A.A.; Fouad, M.A.; Aziz, M.A.; El-Sayed, A. Artichoke Edible Parts Are Hepatoprotective as Commercial Leaf Preparation. Rev. Bras. Farmacogn. 2018, 28, 165–178. [Google Scholar] [CrossRef]
  15. Barracosa, P.; Barracosa, M.; Pires, E. Cardoon as a Sustainable Crop for Biomass and Bioactive Compounds Production. Chem. Biodivers. 2019, 16, e1900498. [Google Scholar] [CrossRef]
  16. Zayed, A.; Farag, M.A. Valorization, Extraction Optimization and Technology Advancements of Artichoke Biowastes: Food and Non-Food Applications. LWT-Food Sci. Technol. 2020, 132, 109883. [Google Scholar] [CrossRef]
  17. Amrani, A.; Al Amrani, H.A.; khalaf Aneed, I. Artichoke and Health (Food and Medicine): A Review. J. Genet. Environ. Resour. Conserv. 2023, 11, 114–124. [Google Scholar]
  18. Al-Subhi, F.M.M. Artichoke as a Tool to Natural Antioxidants for Lowering Diabetics and Hypolipidemia Parameters. Alex. Sci. Exch. J. 2020, 41, 215–224. [Google Scholar] [CrossRef]
  19. Pandino, G.; Lombardo, S.; Mauromicale, G. Chemical and Morphological Characteristics of New Clones and Commercial Varieties of Globe Artichoke (Cynara cardunculus Var. Scolymus). Plant Foods Hum. Human. Nutr. 2011, 66, 291–297. [Google Scholar] [CrossRef]
  20. Lombardo, S.; Pandino, G.; Mauromicale, G.; Knödler, M.; Carle, R.; Schieber, A. Influence of Genotype, Harvest Time and Plant Part on Polyphenolic Composition of Globe Artichoke [Cynara cardunculus L. Var. Scolymus (L.) Fiori]. Food Chem. 2010, 119, 1175–1181. [Google Scholar] [CrossRef]
  21. Raccuia, S.A.; Melilli, M.G. Effect of Storage Temperature and Genotype on Quality of Globe Artichoke [Cynara cardunculus L. Subsp. Scolymus (L.) Hegi] Head. Acta Hortic. 2007, 730, 449–454. [Google Scholar] [CrossRef]
  22. Sękara, A.; Kalisz, A.; Gruszecki, R.; Grabowska, A.; Kunicki, E. Globe Artichoke—A Vegetable Herb and Ornamental of Value in Central Europe: A Review. J. Hortic. Sci. Biotechnol. 2015, 90, 365–374. [Google Scholar] [CrossRef]
  23. Allahdadi, M.; Raey, Y.; Raei, Y. Growth and Chlorogenic Acid Content of Artichoke (Cynara scolymus L.) Affected by Bio and Chemical Fertilizer. J. Biodivers. Environ. Sci. 2017, 11, 63–73. [Google Scholar]
  24. Petropoulos, S.A.; Pereira, C.; Ntatsi, G.; Danalatos, N.; Barros, L.; Ferreira, I.C.F.R. Nutritional Value and Chemical Composition of Greek Artichoke Genotypes. Food Chem. 2018, 267, 296–302. [Google Scholar] [CrossRef] [PubMed]
  25. Alicandri, E.; Paolacci, A.R.; Catarcione, G.; Del Lungo, A.; Iacoponi, V.; Pati, F.; Scarascia Mugnozza, G.; Ciaffi, M. Morphological, Molecular, and Nutritional Characterisation of the Globe Artichoke Landrace “Carciofo Ortano”. Plants 2023, 12, 1844. [Google Scholar] [CrossRef] [PubMed]
  26. Claus, T.; Maruyama, S.A.; Palombini, S.V.; Montanher, P.F.; Bonafé, E.G.; de Oliveira Santos Junior, O.; Matsushita, M.; Visentainer, J.V. Chemical Characterization and Use of Artichoke Parts for Protection from Oxidative Stress in Canola Oil. LWT-Food Sci. Technol. 2015, 61, 346–351. [Google Scholar] [CrossRef]
  27. Magied, M.M.A.; Hussien, S.E.D.; Zaki, S.M.; Said, R.M. EL Artichoke (Cynara scolymus L.) Leaves and Heads Extracts as Hypoglycemic and Hypocholesterolemic in Rats. J. Food Nutr. Res. 2016, 4, 60–68. [Google Scholar] [CrossRef]
  28. Hernández-Hernández, O.; Ruiz-Aceituno, L.; Sanz, M.L.; Martínez-Castro, I. Determination of Free Inositols and Other Low Molecular Weight Carbohydrates in Vegetables. J. Agric. Food Chem. 2011, 59, 2451–2455. [Google Scholar] [CrossRef]
  29. El-Hadidy, G.S.; Elmeshad, W.; Abdelgaleel, M.; Ali, M. Extraction, Identification, and Quantification of Bioactive Compounds from Globe Artichoke (Cynara cardunculus Var. Scolymus). Sains Malays. 2022, 51, 2843–2855. [Google Scholar] [CrossRef]
  30. Hussein, L.; El-Fouly, M.M.; El-Baz, F.K.; Ghanem, S.A. Nutritional Quality and the Presence of Anti-Nutritional Factors in Leaf Protein Concentrates (LPC). Int. J. Food Sci. Nutr. 1999, 50, 333–343. [Google Scholar] [CrossRef]
  31. Francavilla, M.; Marone, M.; Marasco, P.; Contillo, F.; Monteleone, M. Artichoke Biorefinery: From Food to Advanced Technological Applications. Foods 2021, 10, 112. [Google Scholar] [CrossRef]
  32. Dosi, R.; Guida, V.; Severino, V.; Maro, A. Di Nutritional and Metabolic Profiling of the Globe Artichoke (Cynara scolymus L. “Capuanella” Heads) in Province of Caserta, Italy. Aust. J. Crop Sci. 2013, 7, 1927–1934. [Google Scholar]
  33. Food and Agriculture Organization of the United Nations. Fats and Fatty Acids in Human Nutrition: Report of an Expert Consultation: 10–14 November 2008, Geneva; Food and Agriculture Organization of the United Nations: Rome, Italy, 2010; ISBN 978-9-25-106733-8. [Google Scholar]
  34. Sharma, M.; Sharma, M.; Bithel, N.; Sharma, M. Ethnobotany, Phytochemistry, Pharmacology and Nutritional Potential of Medicinal Plants from Asteraceae Family. J. Mt. Res. 2022, 17, 67–83. [Google Scholar] [CrossRef]
  35. Elsebai, M.F.; Mocan, A.; Atanasov, A.G. Cynaropicrin: A Comprehensive Research Review and Therapeutic Potential as an Anti-Hepatitis C Virus Agent. Front. Pharmacol. 2016, 7, 231724. [Google Scholar] [CrossRef]
  36. Eljounaidi, K.; Cankar, K.; Comino, C.; Moglia, A.; Hehn, A.; Bourgaud, F.; Bouwmeester, H.; Menin, B.; Lanteri, S.; Beekwilder, J. Cytochrome P450s from Cynara cardunculus L. CYP71AV9 and CYP71BL5, Catalyze Distinct Hydroxylations in the Sesquiterpene Lactone Biosynthetic Pathway. Plant Sci. 2014, 223, 59–68. [Google Scholar] [CrossRef] [PubMed]
  37. de Falco, B.; Incerti, G.; Amato, M.; Lanzotti, V. Artichoke: Botanical, Agronomical, Phytochemical, and Pharmacological Overview. Phytochem. Rev. 2015, 14, 993–1018. [Google Scholar] [CrossRef]
  38. Rocchetti, G.; Lucini, L.; Corrado, G.; Colla, G.; Cardarelli, M.; de Pascale, S.; Rouphael, Y. Phytochemical Profile, Mineral Content, and Bioactive Compounds in Leaves of Seed-Propagated Artichoke Hybrid Cultivars. Molecules 2020, 25, 3795. [Google Scholar] [CrossRef] [PubMed]
  39. Shubham, K.; Anukiruthika, T.; Dutta, S.; Kashyap, A.V.; Moses, J.A.; Anandharamakrishnan, C. Iron Deficiency Anemia: A Comprehensive Review on Iron Absorption, Bioavailability and Emerging Food Fortification Approaches. Trends Food Sci. Technol. 2020, 99, 58–75. [Google Scholar] [CrossRef]
  40. Suh, S.W.; Won, S.J.; Hamby, A.M.; Yoo, B.H.; Fan, Y.; Sheline, C.T.; Tamano, H.; Takeda, A.; Liu, J. The Important Role of Zinc in Neurological Diseases. Biomolecules 2022, 13, 28. [Google Scholar] [CrossRef]
  41. Wessels, I.; Fischer, H.J.; Rink, L. Dietary and Physiological Effects of Zinc on the Immune System. Annu. Rev. Nutr. 2021, 41, 133–175. [Google Scholar] [CrossRef]
  42. Eman, A.M.; Wafaa; Hanem, M. Evaluation of Globe Artichoke By-Products for Enhancing Functional Properties of Some Foods. J. Adv. Agric. Res. 2018, 112, 112–129. [Google Scholar]
  43. Pandino, G.; Lombardo, S.; Mauromicale, G. Mineral Profile in Globe Artichoke as Affected by Genotype, Head Part and Environment. J. Sci. Food Agric. 2011, 91, 302–308. [Google Scholar] [CrossRef] [PubMed]
  44. Mirmiran, P.; Bahadoran, Z.; Nazeri, P.; Azizi, F. Dietary Sodium to Potassium Ratio and the Incidence of Hypertension and Cardiovascular Disease: A Population-Based Longitudinal Study. Clin. Exp. Hypertens. 2018, 40, 772–779. [Google Scholar] [CrossRef] [PubMed]
  45. Carr, A.C.; Maggini, S. Vitamin C and Immune Function. Nutrients 2017, 9, 1211. [Google Scholar] [CrossRef] [PubMed]
  46. Biel, W.; Witkowicz, R.; Piątkowska, E.; Podsiadło, C. Proximate Composition, Minerals and Antioxidant Activity of Artichoke Leaf Extracts. Biol. Trace Elem. Res. 2020, 194, 589–595. [Google Scholar] [CrossRef] [PubMed]
  47. Lombardo, S.; Pandino, G.; Mauro, R.P.; Mauromicale, G. Mineral Profile in the Floral Stem of Some Globe Artichoke Cultivars. Acta Hortic. 2013, 983, 433–437. [Google Scholar] [CrossRef]
  48. Colla, G.; Rouphael, Y.; Cardarelli, M.; Svecova, E.; Rea, E.; Lucini, L. Effects of Saline Stress on Mineral Composition, Phenolic Acids and Flavonoids in Leaves of Artichoke and Cardoon Genotypes Grown in Floating System. J. Sci. Food Agric. 2013, 93, 1119–1127. [Google Scholar] [CrossRef] [PubMed]
  49. Grigelmo-Miguel, N.; Martmh N-Belloso, O. Comparison of Dietary Fibre from By-Products of Processing Fruits and Greens and from Cereals. LWT-Food Sci. Technol. 1999, 32, 503–508. [Google Scholar] [CrossRef]
  50. Quintero Ruiz, N.A.; Paolucci, M.; Siano, F.; Mamone, G.; Picariello, G.; Puppo, M.C.; Cascone, G.; Volpe, M.G. Characterization of Soluble and Insoluble Fibers in Artichoke By-Products by ATR-FTIR Spectroscopy Coupled with Chemometrics. Int. J. Food Prop. 2021, 24, 1693–1704. [Google Scholar] [CrossRef]
  51. Boubaker, M.; Omri, A.E.L.; Blecker, C.; Bouzouita, N. Fibre Concentrate from Artichoke (Cynara scolymus L.) Stem by-Products: Characterization and Application as a Bakery Product Ingredient. Food Sci. Technol. Int. 2016, 22, 759–768. [Google Scholar] [CrossRef]
  52. Fissore, E.N.; Domingo, C.S.; Pujol, C.A.; Damonte, E.B.; Rojas, A.M.; Gerschenson, L.N. Upgrading of Residues of Bracts, Stems and Hearts of Cynara cardunculus L. Var. Scolymus to Functional Fractions Enriched in Soluble Fiber. Food Funct. 2014, 5, 463–470. [Google Scholar] [CrossRef]
  53. Gil-Izquierdo, A.; Gil, M.I.; Conesa, M.A.; Ferreres, F. The Effect of Storage Temperatures on Vitamin C and Phenolics Content of Artichoke (Cynara scolymus L.) Heads. Innov. Food Sci. Emerg. Technol. 2001, 2, 199–202. [Google Scholar] [CrossRef]
  54. Cavini, S.; Guzzetti, L.; Givoia, F.; Regonesi, M.E.; Di Gennaro, P.; Magoni, C.; Campone, L.; Labra, M.; Bruni, I. Artichoke (Cynara cardunculus Var. Scolymus L.) by-Products as a Source of Inulin: How to Valorise an Agricultural Supply Chain Extracting an Added-Value Compound. Nat. Prod. Res. 2022, 36, 2140–2144. [Google Scholar] [CrossRef] [PubMed]
  55. Pandino, G.; Lombardo, S.; Lo Monaco, A.; Mauromicale, G. Choice of Time of Harvest Influences the Polyphenol Profile of Globe Artichoke. J. Funct. Foods 2013, 5, 1822–1828. [Google Scholar] [CrossRef]
  56. Schütz, K.; Persike, M.; Carle, R.; Schieber, A. Characterization and Quantification of Anthocyanins in Selected Artichoke (Cynara scolymus L.) Cultivars by HPLC-DAD-ESI-MSn. Anal. Bioanal. Chem. 2006, 384, 1511–1517. [Google Scholar] [CrossRef] [PubMed]
  57. Lombardo, S.; Pandino, G.; Mauromicale, G. The Influence of Pre-Harvest Factors on the Quality of Globe Artichoke. Sci. Hortic. 2018, 233, 479–490. [Google Scholar] [CrossRef]
  58. Romo-Hualde, A.; Sáiz-Abajo, M.J.; Yetano-Cunchillos, A.I.; González-Ferrero, C.; Alonso-Santibanez, D.; Salvadó-Casadevall, M.; Lahoz, I.; Macua, J.I. Characterization of Bioactive Substances in Various Artichoke Varieties. Acta Hortic. 2012, 942, 395–400. [Google Scholar] [CrossRef]
  59. Ahmad El-Sohaimy, S. The Effect of Cooking on the Chemical Composition of Artichoke (Cynara scolymus L.). Afr. J. Food Sci. Technol. 2013, 4, 182–187. [Google Scholar] [CrossRef]
  60. Kalala, G.; Kambashi, B.; Everaert, N.; Beckers, Y.; Richel, A.; Pachikian, B.; Neyrinck, A.M.; Delzenne, N.M.; Bindelle, J. Characterization of Fructans and Dietary Fibre Profiles in Raw and Steamed Vegetables. Int. J. Food Sci. Nutr. 2018, 69, 682–689. [Google Scholar] [CrossRef]
  61. Abedo, A.; Salman, F.M.; El-Nomeary, Y.A.A.; Abedo, A.A.; Abd El-Rahman, H.H.; Mohamed, M.I.; Ahmed, S.M. Utilization of Artichoke (Cynara scolymus) By-Products in Sheep Feeding. J. Agric. Environ. Sci. 2014, 14, 624–630. [Google Scholar] [CrossRef]
  62. Christaki, E.; Bonos, E.; Florou-Paneri, P. Nutritional and Functional Properties of Cynara Crops (Globe Artichoke and Cardoon) and Their Potential Applications: A Review. Int. J. Appl. Sci. Technol. 2012, 2, 64–70. [Google Scholar]
  63. Wan, X.; Guo, H.; Liang, Y.; Zhou, C.; Liu, Z.; Li, K.; Niu, F.; Zhai, X.; Wang, L. The Physiological Functions and Pharmaceutical Applications of Inulin: A Review. Carbohydr. Polym. 2020, 246, 116589. [Google Scholar] [CrossRef] [PubMed]
  64. Leroy, G.; Grongnet, J.F.; Mabeau, S.; le Corre, D.; Baty-Julien, Ć. Changes in Inulin and Soluble Sugar Concentration in Artichokes (Cynara scolymus L.) during Storage. J. Sci. Food Agric. 2010, 90, 1203–1209. [Google Scholar] [CrossRef] [PubMed]
  65. Ruiz-Cano, D.; Pérez-Llamas, F.; Frutos, M.J.; Arnao, M.B.; Espinosa, C.; López-Jiménez, J.Á.; Castillo, J.; Zamora, S. Chemical and Functional Properties of the Different By-Products of Artichoke (Cynara scolymus L.) from Industrial Canning Processing. Food Chem. 2014, 160, 134–140. [Google Scholar] [CrossRef] [PubMed]
  66. Fissore, E.N.; Santo Domingo, C.; Gerschenson, L.N.; Giannuzzi, L. A Study of the Effect of Dietary Fiber Fractions Obtained from Artichoke (Cynara cardunculus L. Var. Scolymus) on the Growth of Intestinal Bacteria Associated with Health. Food Funct. 2015, 6, 1667–1674. [Google Scholar] [CrossRef] [PubMed]
  67. Ahlawat, Y.K.; Singh, M.; Manorama, K.; Lakra, N.; Zaid, A.; Zulfiqar, F. Plant Phenolics: Neglected Secondary Metabolites in Plant Stress Tolerance. Braz. J. Bot. 2023, 1–19. [Google Scholar] [CrossRef]
  68. Feiden, T.; Valduga, E.; Zeni, J.; Steffens, J. Bioactive Compounds from Artichoke and Application Potential. Food Technol. Biotechnol. 2023, 61, 312–327. [Google Scholar] [CrossRef] [PubMed]
  69. Zhu, X.; Zhang, H.; Lo, R. Phenolic Compounds from the Leaf Extract of Artichoke (Cynara scolymus L.) and Their Antimicrobial Activities. J. Agric. Food Chem. 2004, 52, 7272–7278. [Google Scholar] [CrossRef] [PubMed]
  70. Romani, A.; Pinelli, P.; Cantini, C.; Cimato, A.; Heimler, D. Characterization of Violetto Di Toscana, a Typical Italian Variety of Artichoke (Cynara scolymus L.). Food Chem. 2006, 95, 221–225. [Google Scholar] [CrossRef]
  71. Ben Salem, M.; Affes, H.; Athmouni, K.; Ksouda, K.; Dhouibi, R.; Sahnoun, Z.; Hammami, S.; Zeghal, K.M. Chemicals Compositions, Antioxidant and Anti-Inflammatory Activity of Cynara scolymus Leaves Extracts, and Analysis of Major Bioactive Polyphenols by HPLC. Evid. Based Complement. Altern. Med. 2017, 2017, 4951937. [Google Scholar] [CrossRef]
  72. Xia, N.; Pautz, A.; Wollscheid, U.; Reifenberg, G.; Förstermann, U.; Li, H. Artichoke, Cynarin and Cyanidin Downregulate the Expression of Inducible Nitric Oxide Synthase in Human Coronary Smooth Muscle Cells. Molecules 2014, 19, 3654–3668. [Google Scholar] [CrossRef]
  73. Montesano, V.; Negro, D.; Sonnante, G.; Laghetti, G.; Urbano, M. Polyphenolic Compound Variation in Globe Artichoke Cultivars as Affected by Fertilization and Biostimulants Application. Plants 2022, 11, 2067. [Google Scholar] [CrossRef] [PubMed]
  74. Lim, T.K. Edible Medicinal and Non-Medicinal Plants. In Edible Medicinal and Non-Medicinal Plants; Springer: Berlin/Heidelberg, Germany, 2012; Volume 1, pp. 1–738. [Google Scholar] [CrossRef]
  75. Pompili, V.; Mazzocchi, E.; Moglia, A.; Acquadro, A.; Comino, C.; Rotino, G.L.; Lanteri, S. Structural and Expression Analysis of Polyphenol Oxidases Potentially Involved in Globe Artichoke (C. Cardunculus Var. Scolymus L.) Tissue Browning. Sci. Rep. 2023, 13, 12288. [Google Scholar] [CrossRef] [PubMed]
  76. Zhang, S. Recent Advances of Polyphenol Oxidases in Plants. Molecules 2023, 28, 2158. [Google Scholar] [CrossRef] [PubMed]
  77. Llorach, R.; Espín, J.C.; Tomás-Barberán, F.A.; Ferreres, F. Artichoke (Cynara scolymus L.) Byproducts as a Potential Source of Health-Promoting Antioxidant Phenolics. J. Agric. Food Chem. 2002, 50, 3458–3464. [Google Scholar] [CrossRef] [PubMed]
  78. Sanz, S.; Olarte, C.; Ayala, F.; Echávarri, J.F. Evolution of Quality Characteristics of Minimally Processed Asparagus during Storage in Different Lighting Conditions. J. Food Sci. 2009, 74, S296–S302. [Google Scholar] [CrossRef] [PubMed]
  79. Todaro, A.; Peluso, O.; Catalano, A.E.; Mauromicale, G.; Spagna, G. Polyphenol Oxidase Activity from Three Sicilian Artichoke [ Cynara cardunculus L. Var. Scolymus L. (Fiori)] Cultivars: Studies and Technological Application on Minimally Processed Production. J. Agric. Food Chem. 2010, 58, 1714–1718. [Google Scholar] [CrossRef] [PubMed]
  80. Llorente, B.E.; Obregón, W.D.; Avilés, F.X.; Caffini, N.O.; Vairo-Cavalli, S. Use of Artichoke (Cynara scolymus) Flower Extract as a Substitute for Bovine Rennet in the Manufacture of Gouda-Type Cheese: Characterization of Aspartic Proteases. Food Chem. 2014, 159, 55–63. [Google Scholar] [CrossRef] [PubMed]
  81. Curti, E.; Anedda, R.; Pacifico, S.; Caputo, E.; Piccolella, S.; Mandrich, L. Exploring New Fruit- and Vegetable-Derived Rennet for Cheese Making. Appl. Sci. 2024, 14, 2257. [Google Scholar] [CrossRef]
  82. Nicosia, F.D.; Puglisi, I.; Pino, A.; Caggia, C.; Randazzo, C.L. Plant Milk-Clotting Enzymes for Cheesemaking. Foods 2022, 11, 871. [Google Scholar] [CrossRef]
  83. Tiveron, A.P.; Melo, P.S.; Bergamaschi, K.B.; Vieira, T.M.F.S.; Regitano-d’Arce, M.A.B.; Alencar, S.M. Antioxidant Activity of Brazilian Vegetables and Its Relation with Phenolic Composition. Int. J. Mol. Sci. 2012, 13, 8943–8957. [Google Scholar] [CrossRef]
  84. Rejeb, I.B.; Dhen, N.; Gargouri, M.; Boulila, A. Chemical Composition, Antioxidant Potential and Enzymes Inhibitory Properties of Globe Artichoke By-Products. Chem. Biodivers. 2020, 17, e2000073. [Google Scholar] [CrossRef] [PubMed]
  85. Zapolska-Downar, D.; Zapolski-Downar, A.; Naruszewicz, M.; Siennicka, A.; Krasnodbska, B.; Kolodziej, B. Protective Properties of Artichoke (Cynara scolymus) against Oxidative Stress Induced in Cultured Endothelial Cells and Monocytes. Life Sci. 2002, 71, 2897–2908. [Google Scholar] [CrossRef] [PubMed]
  86. Carpentieri, S.; Augimeri, G.; Ceramella, J.; Vivacqua, A.; Sinicropi, M.S.; Pataro, G.; Bonofiglio, D.; Ferrari, G. Antioxidant and Anti-Inflammatory Effects of Extracts from Pulsed Electric Field-Treated Artichoke By-Products in Lipopolysaccharide-Stimulated Human THP-1 Macrophages. Foods 2022, 11, 2250. [Google Scholar] [CrossRef] [PubMed]
  87. D’Antuono, I.; Garbetta, A.; Linsalata, V.; Minervini, F.; Cardinali, A. Polyphenols from Artichoke Heads (Cynara cardunculus (L.) Subsp. Scolymus Hayek): In Vitro Bio-Accessibility, Intestinal Uptake and Bioavailability. Food Funct. 2015, 6, 1268–1277. [Google Scholar] [CrossRef] [PubMed]
  88. Ben Salem, M.; Ben Abdallah Kolsi, R.; Dhouibi, R.; Ksouda, K.; Charfi, S.; Yaich, M.; Hammami, S.; Sahnoun, Z.; Zeghal, K.M.; Jamoussi, K.; et al. Protective Effects of Cynara scolymus Leaves Extract on Metabolic Disorders and Oxidative Stress in Alloxan-Diabetic Rats. BMC Complement. Altern. Med. 2017, 17, 328. [Google Scholar] [CrossRef] [PubMed]
  89. El-Boshy, M.; Ashshi, A.; Gaith, M.; Qusty, N.; Bokhary, T.; AlTaweel, N.; Abdelhady, M. Studies on the Protective Effect of the Artichoke (Cynara scolymus) Leaf Extract against Cadmium Toxicity-Induced Oxidative Stress, Hepatorenal Damage, and Immunosuppressive and Hematological Disorders in Rats. Environ. Sci. Pollut. Res. 2017, 24, 12372–12383. [Google Scholar] [CrossRef]
  90. Tang, X.; Wei, R.; Deng, A.; Lei, T. Protective Effects of Ethanolic Extracts from Artichoke, an Edible Herbal Medicine, against Acute Alcohol-Induced Liver Injury in Mice. Nutrients 2017, 9, 1000. [Google Scholar] [CrossRef] [PubMed]
  91. Jaleel, G.; Saleh, D.; El-Awdan, S. Beneficial Effect of Artichoke Leaf Extract on Ethylene Glycol-Induced Urolithiasis in Rats. Int. J. Pharmacogn. Phytochem. Res. 2016, 8, 960–967. [Google Scholar]
  92. Deng, A.; Wang, Y.; Huang, K.; Xie, P.; Mo, P.; Liu, F.; Chen, J.; Chen, K.; Wang, Y.; Xiao, B. Artichoke (Cynara scolymus L.) Water Extract Alleviates Palmitate-Induced Insulin Resistance in HepG2 Hepatocytes via the Activation of IRS1/PI3K/AKT/FoxO1 and GSK-3β Signaling Pathway. BMC Complement. Med. Ther. 2023, 23, 460. [Google Scholar] [CrossRef]
  93. Miccadei, S.; Venere, D.D.; Cardinali, A.; Romano, F.; Durazzo, A.; Foddai, M.S.; Fraioli, R.; Mobarhan, S.; Maiani, G. Antioxidative and Apoptotic Properties of Polyphenolic Extracts from Edible Part of Artichoke (Cynara scolymus L.) on Cultured Rat Hepatocytes and on Human Hepatoma Cells. Nutr. Cancer 2008, 60, 276–283. [Google Scholar] [CrossRef]
  94. El Morsy, E.M.; Kamel, R. Protective Effect of Artichoke Leaf Extract against Paracetamol-Induced Hepatotoxicity in Rats. Pharm. Biol. 2015, 53, 167–173. [Google Scholar] [CrossRef]
  95. Celepli, S.; Çolak, B.; Celepli, P.; Bigat, İ.; Batur, H.G.; Soysal, F.; Karakurt, S.; Hücümenoğlu, S.; Kısmet, K.; Şahin, M. Effects of Artichoke Leaf Extract on Hepatic Ischemia-Reperfusion Injury. Rev. Assoc. Med. Bras. 2021, 68, 87–93. [Google Scholar] [CrossRef] [PubMed]
  96. Heidarian, E.; Rafieian-Kopaei, M. Protective Effect of Artichoke (Cynara scolymus) Leaf Extract against Lead Toxicity in Rat. Pharm. Biol. 2013, 51, 1104–1109. [Google Scholar] [CrossRef] [PubMed]
  97. Musolino, V.; Gliozzi, M.; Bombardelli, E.; Nucera, S.; Carresi, C.; Maiuolo, J.; Mollace, R.; Paone, S.; Bosco, F.; Scarano, F.; et al. The Synergistic Effect of Citrus Bergamia and Cynara cardunculus Extracts on Vascular Inflammation and Oxidative Stress in Non-Alcoholic Fatty Liver Disease. J. Tradit. Complement. Med. 2020, 10, 268–274. [Google Scholar] [CrossRef]
  98. Rangboo, V.; Noroozi, M.; Zavoshy, R.; Rezadoost, S.A.; Mohammadpoorasl, A. The Effect of Artichoke Leaf Extract on Alanine Aminotransferase and Aspartate Aminotransferase in the Patients with Nonalcoholic Steatohepatitis. Int. J. Hepatol. 2016, 2016, 4030476. [Google Scholar] [CrossRef]
  99. Panahi, Y.; Kianpour, P.; Mohtashami, R.; Atkin, S.L.; Butler, A.E.; Jafari, R.; Badeli, R.; Sahebkar, A. Efficacy of Artichoke Leaf Extract in Non-Alcoholic Fatty Liver Disease: A Pilot Double-Blind Randomized Controlled Trial. Phytother. Res. 2018, 32, 1382–1387. [Google Scholar] [CrossRef]
  100. Van den Abbeele, P.; Ghyselinck, J.; Marzorati, M.; Villar, A.; Zangara, A.; Smidt, C.R.; Risco, E. In Vitro Evaluation of Prebiotic Properties of a Commercial Artichoke Inflorescence Extract Revealed Bifidogenic Effects. Nutrients 2020, 12, 1552. [Google Scholar] [CrossRef]
  101. Holgado, F.; Campos-Monfort, G.; de las Heras, C.; Rupérez, P. Assessment of the Prebiotic Potential of Globe Artichoke By-Product through in Vitro Fermentation by Human Faecal Microbiota. Bioact. Carbohydr. Diet. Fibre 2022, 28, 100328. [Google Scholar] [CrossRef]
  102. Vacca, M.; Pinto, D.; Annunziato, A.; Ressa, A.; Calasso, M.; Pontonio, E.; Celano, G.; De Angelis, M. Gluten-Free Bread Enriched with Artichoke Leaf Extract In Vitro Exerted Antioxidant and Anti-Inflammatory Properties. Antioxidants 2023, 12, 845. [Google Scholar] [CrossRef]
  103. Mateus, V.; Estarreja, J.; Silva, I.; Barracosa, P.; Teixeira-Lemos, E.; Pinto, R. Effect of Cynara cardunculus L. Var. Altilis (DC) in Inflammatory Bowel Disease. Appl. Sci. 2021, 11, 1629. [Google Scholar] [CrossRef]
  104. Sabater, C.; Molina-Tijeras, J.A.; Vezza, T.; Corzo, N.; Montilla, A.; Utrilla, P. Intestinal Anti-Inflammatory Effects of Artichoke Pectin and Modified Pectin Fractions in the Dextran Sulfate Sodium Model of Mice Colitis. Artificial Neural Network Modelling of Inflammatory Markers. Food Funct. 2019, 10, 7793–7805. [Google Scholar] [CrossRef] [PubMed]
  105. Costabile, A.; Kolida, S.; Klinder, A.; Gietl, E.; Buerlein, M.; Frohberg, C.; Landschtze, V.; Gibson, G.R. A Double-Blind, Placebo-Controlled, Cross-over Study to Establish the Bifidogenic Effect of a Very-Long-Chain Inulin Extracted from Globe Artichoke (Cynara scolymus) in Healthy Human Subjects. Br. J. Nutr. 2010, 104, 1007–1017. [Google Scholar] [CrossRef] [PubMed]
  106. Heidarian, E.; Soofiniya, Y. Hypolipidemic and Hypoglycemic Effects of Aerial Part of Cynara scolymus in Streptozotocin-Induced Diabetic Rats. J. Med. Plants Res. 2011, 5, 2717–2723. [Google Scholar]
  107. Alves, I.; Carvalho, B.; Terra, M.; Oliveira, C.H.; Silva, A.; Costa, M.; Rodrigues, R.; Barros, G.; Salles, B. Effects of artichoke (Cynara Scolumus L.) extract on biochemical parameters in diabetic rats. Authorea Prepr. 2020. [Google Scholar] [CrossRef]
  108. Rondanelli, M.; Riva, A.; Petrangolini, G.; Allegrini, P.; Bernardinelli, L.; Fazia, T.; Peroni, G.; Gasparri, C.; Nichetti, M.; Faliva, M.A.; et al. The Metabolic Effects of Cynara Supplementation in Overweight and Obese Class I Subjects with Newly Detected Impaired Fasting Glycemia: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Nutrients 2020, 12, 3298. [Google Scholar] [CrossRef] [PubMed]
  109. Rondanelli, M.; Opizzi, A.; Faliva, M.; Sala, P.; Perna, S.; Riva, A.; Morazzoni, P.; Bombardelli, E.; Giacosa, A. Metabolic Management in Overweight Subjects with Naive Impaired Fasting Glycaemia by Means of a Highly Standardized Extract From Cynara scolymus: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Phytother. Res. 2014, 28, 33–41. [Google Scholar] [CrossRef] [PubMed]
  110. Nazni, P.; Poongodi Vijayakumar, T.; Alagianambi, P.; Amirthaveni, M. Hypoglycemic and Hypolipidemic Effect of Cynara scolymus among Selected Type 2 Diabetic Individuals. Pak. J. Nutr. 2006, 5, 147–151. [Google Scholar]
  111. Frigerio, J.; Tedesco, E.; Benetti, F.; Insolia, V.; Nicotra, G.; Mezzasalma, V.; Pagliari, S.; Labra, M.; Campone, L. Anticholesterolemic Activity of Three Vegetal Extracts (Artichoke, Caigua, and Fenugreek) and Their Unique Blend. Front. Pharmacol. 2021, 12, 726199. [Google Scholar] [CrossRef] [PubMed]
  112. Ben Salem, M.; Affes, H.; Dhouibi, R.; Charfi, S.; Turki, M.; Hammami, S.; Ayedi, F.; Sahnoun, Z.; Zeghal, K.M.; Ksouda, K. Effect of Artichoke (Cynara scolymus) on Cardiac Markers, Lipid Profile and Antioxidants Levels in Tissue of HFD-Induced Obesity. Arch. Physiol. Biochem. 2022, 128, 184–194. [Google Scholar] [CrossRef]
  113. Mocelin, R.; Marcon, M.; Santo, G.D.; Zanatta, L.; Sachett, A.; Schönell, A.P.; Bevilaqua, F.; Giachini, M.; Chitolina, R.; Wildner, S.M.; et al. Hypolipidemic and Antiatherogenic Effects of Cynara scolymus in Cholesterol-Fed Rats. Rev. Bras. Farmacogn. 2016, 26, 233–239. [Google Scholar] [CrossRef]
  114. Mejri, F.; Baati, T.; Martins, A.; Selmi, S.; Luisa Serralheiro, M.; Falé, P.L.; Rauter, A.; Casabianca, H.; Hosni, K. Phytochemical Analysis and in Vitro and in Vivo Evaluation of Biological Activities of Artichoke (Cynara scolymus L.) Floral Stems: Towards the Valorization of Food by-Products. Food Chem. 2020, 333, 127506. [Google Scholar] [CrossRef]
  115. Villanueva-Suárez, M.J.; Mateos-Aparicio, I.; Pérez-Cózar, M.L.; Yokoyama, W.; Redondo-Cuenca, A. Hypolipidemic Effects of Dietary Fibre from an Artichoke By-Product in Syrian Hamsters. J. Funct. Foods 2019, 56, 156–162. [Google Scholar] [CrossRef]
  116. Roghani-Dehkordi, F.; Kamkhah, A.F. Artichoke Leaf Juice Contains Antihypertensive Effect in Patients with Mild Hypertension. J. Diet. Suppl. 2009, 6, 328–341. [Google Scholar] [CrossRef]
  117. Rondanelli, M.; Castellazzi, A.M.; Riva, A.; Allegrini, P.; Faliva, M.A.; Peroni, G.; Naso, M.; Nichetti, M.; Tagliacarne, C.; Valsecchi, C.; et al. Natural Killer Response and Lipo-Metabolic Profile in Adults with Low HDL-Cholesterol and Mild Hypercholesterolemia: Beneficial Effects of Artichoke Leaf Extract Supplementation. Evid.-Based Complement. Altern. Med. 2019, 2019, 2069701. [Google Scholar] [CrossRef] [PubMed]
  118. Cicero, A.F.G.; Fogacci, F.; Bove, M.; Giovannini, M.; Veronesi, M.; Borghi, C. Short-Term Effects of Dry Extracts of Artichokeand Berberis in Hypercholesterolemic Patients without Cardiovascular Disease. Am. J. Cardiol. 2019, 123, 588–591. [Google Scholar] [CrossRef] [PubMed]
  119. Iglesias-Carres, L.; Bruno, A.; D’antuono, I.; Linsalata, V.; Cardinali, A.; Neilson, A.P. In Vitro Evidences of the Globe Artichoke Antioxidant, Cardioprotective and Neuroprotective Effects. J. Funct. Foods 2023, 107, 1756–4646. [Google Scholar] [CrossRef]
  120. Piccinini, A.; Oliveira, M.P.; Silva, M.R.; Bett, G.S.; Becker, I.B.; Mendes, T.F.; Salla, D.H.; Silva, L.E.; Vilela, T.C.; Moraes, F.M.; et al. Effects of Ethanolic Extract of Cynara cardunculus (Artichoke) Leaves on Neuroinflammatory and Neurochemical Parameters in a Diet-Induced Mice Obesity Model. Neurochem. Res. 2022, 47, 1888–1903. [Google Scholar] [CrossRef]
  121. Ibrahim, E.A.; Yousef, M.I.; Ghareeb, D.A.; Augustyniak, M.; Giesy, J.P.; Aboul-Soud, M.A.M.; El Wakil, A. Artichoke Leaf Extract-Mediated Neuroprotection against Effects of Aflatoxin in Male Rats. Biomed. Res. Int. 2022, 2022, 4421828. [Google Scholar] [CrossRef] [PubMed]
  122. Elsayyad, A.; Reyad, Y.A.; Elshafey, B.A.; Aziz, E.K.; Metwally, M.M.M.; Abd-Elhakim, Y.M.; Abdel-Warith, A.-W.A.; Younis, E.M.; Davies, S.J.; El-Houseiny, W.; et al. Artichoke (Cynara scolymus) Leaf Extract Abates the Neurotoxic and Neurobehavioral Outcomes of Fluoride in Nile Tilapia (Oreochromis Niloticus) via Balancing Oxidative Stress, Inflammation, Apoptosis, and Acetylcholinesterase Activity. Aquaculture 2024, 584, 740684. [Google Scholar] [CrossRef]
  123. Mekkey, S.M.; Rahmah, A.; Raghif, A.; Abdul, H.; Alkafaji, R.; Hadi, N.R. The Anti-Parkinson Effects of Cyanara Scoluymus (Artichoke) Extract in Rat Model of Rotenone Induced Parkinsonism. Ann. Rom. Soc. Cell Biol. 2021, 25, 2318–2329. [Google Scholar]
  124. Cicek, B.; Genc, S.; Yeni, Y.; Kuzucu, M.; Cetin, A.; Yildirim, S.; Bolat, I.; Kantarci, M.; Hacimuftuoglu, A.; Lazopoulos, G.; et al. Artichoke (Cynara scolymus) Methanolic Leaf Extract Alleviates Diethylnitrosamine-Induced Toxicity in BALB/c Mouse Brain: Involvement of Oxidative Stress and Apoptotically Related Klotho/PPARγ Signaling. J. Pers. Med. 2022, 12, 2012. [Google Scholar] [CrossRef]
  125. Moradi, M.; Sohrabi, G.; Golbidi, M.; Yarmohammadi, S.; Hemati, N.; Campbell, M.S.; Moradi, S.; Kermani, M.a.H.; Farzaei, M.H. Effects of Artichoke on Blood Pressure: A Systematic Review and Meta-Analysis. Complement. Ther. Med. 2021, 57, 102668. [Google Scholar] [CrossRef] [PubMed]
  126. Valko, M.; Leibfritz, D.; Moncol, J.; Cronin, M.T.D.; Mazur, M.; Telser, J. Free Radicals and Antioxidants in Normal Physiological Functions and Human Disease. Int. J. Biochem. Cell Biol. 2007, 39, 44–84. [Google Scholar] [CrossRef]
  127. Lattanzio, V.; Cicco, N.; Linsalata, V. Antioxidant Activities of Artichoke Phenolics. Acta Hortic. 2005, 681, 421–428. [Google Scholar] [CrossRef]
  128. Divyajanani, S.; Harithpriya, K.; Ganesan, K.; Ramkumar, K.M. Dietary Polyphenols Remodel DNA Methylation Patterns of NRF2 in Chronic Disease. Nutrients 2023, 15, 3347. [Google Scholar] [CrossRef] [PubMed]
  129. Zhou, Y.; Jiang, Z.; Lu, H.; Xu, Z.; Tong, R.; Shi, J.; Jia, G. Recent Advances of Natural Polyphenols Activators for Keap1-Nrf2 Signaling Pathway. Chem. Biodivers. 2019, 16, e1900400. [Google Scholar] [CrossRef]
  130. Takei, K.; Hashimoto-Hachiya, A.; Takahara, M.; Tsuji, G.; Nakahara, T.; Furue, M. Cynaropicrin Attenuates UVB-Induced Oxidative Stress via the AhR-Nrf2-Nqo1 Pathway. Toxicol. Lett. 2015, 234, 74–80. [Google Scholar] [CrossRef] [PubMed]
  131. Kamel, A.M.; Farag, M.A. Therapeutic Potential of Artichoke in the Treatment of Fatty Liver: A Systematic Review and Meta-Analysis. J. Med. Food 2022, 25, 931–942. [Google Scholar] [CrossRef]
  132. Amini, M.R.; Sheikhhossein, F.; Talebyan, A.; Bazshahi, E.; Djafari, F.; Hekmatdoost, A. Effects of Artichoke Supplementation on Liver Enzymes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Clin. Nutr. Res. 2022, 11, 228–239. [Google Scholar] [CrossRef]
  133. Moradi, S.; Shokri-Mashhadi, N.; Saraf-Bank, S.; Mohammadi, H.; Zobeiri, M.; Clark, C.C.T.; Rouhani, M.H. The Effects of Cynara scolymus L. Supplementation on Liver Enzymes: A Systematic Review and Meta-Analysis. Int. J. Clin. Pract. 2021, 75, e14726. [Google Scholar] [CrossRef]
  134. Younossi, Z.; Anstee, Q.M.; Marietti, M.; Hardy, T.; Henry, L.; Eslam, M.; George, J.; Bugianesi, E. Global Burden of NAFLD and NASH: Trends, Predictions, Risk Factors and Prevention. Nat. Rev. Gastroenterol. Hepatol. 2018, 15, 11–20. [Google Scholar] [CrossRef]
  135. Neuman, M.G.; Cohen, L.B.; Nanau, R.M. Biomarkers in Nonalcoholic Fatty Liver Disease. Can. J. Gastroenterol. Hepatol. 2014, 28, 607–618. [Google Scholar] [CrossRef]
  136. Liu, X.; Huang, K.; Niu, Z.; Mei, D.; Zhang, B. Protective Effect of Isochlorogenic Acid B on Liver Fibrosis in Non-Alcoholic Steatohepatitis of Mice. Basic Clin. Pharmacol. Toxicol. 2019, 124, 144–153. [Google Scholar] [CrossRef]
  137. Al-Jameil Dr, N.; Khan, F.A.; Arjumand, S.; Khan, M.F.; Tabassum, H. Associated Liver Enzymes with Hyperlipidemic Profile in Type 2 Diabetes Patients. Int. J. Clin. Exp. Pathol. 2014, 7, 4345. [Google Scholar]
  138. Fritsche, J.; Beindorff, C.M.; Dachtler, M.; Zhang, H.; Lammers, J.G. Isolation, Characterization and Determination of Minor Artichoke (Cynara scolymus L.) Leaf Extract Compounds. Eur. Food Res. Technol. 2002, 215, 149–157. [Google Scholar] [CrossRef]
  139. Holgado, F.; Campos-Monfort, G.; de las Heras, C.; Rupérez, P. In Vitro Fermentability of Globe Artichoke By-Product by Lactobacillus acidophilus and Bifidobacterium bifidum. Bioact. Carbohydr. Diet. Fibre 2021, 26, 100286. [Google Scholar] [CrossRef]
  140. Bundy, R.; Walker, A.F.; Middleton, R.W.; Marakis, G.; Booth, J.C.L. Artichoke Leaf Extract Reduces Symptoms of Irritable Bowel Syndrome and Improves Quality of Life in Otherwise Healthy Volunteers Suffering from Concomitant Dyspepsia: A Subset Analysis. J. Altern. Complement. Med. 2004, 10, 667–669. [Google Scholar] [CrossRef]
  141. Holtmann, G.; Adam, B.; Haag, S.; Collet, W.; Grünewald, E.; Windeck, T. Efficacy of Artichoke Leaf Extract in the Treatment of Patients with Functional Dyspepsia: A Six-Week Placebo-Controlled, Double-Blind, Multicentre Trial. Aliment. Pharmacol. Ther. 2003, 18, 1099–1105. [Google Scholar] [CrossRef]
  142. Haneishi, Y.; Furuya, Y.; Hasegawa, M.; Picarelli, A.; Rossi, M.; Miyamoto, J. Inflammatory Bowel Diseases and Gut Microbiota. Int. J. Mol. Sci. 2023, 24, 3817. [Google Scholar] [CrossRef]
  143. Sharma, M.; Wasan, A.; Sharma, R.K. Recent Developments in Probiotics: An Emphasis on Bifidobacterium. Food Biosci. 2021, 41, 100993. [Google Scholar] [CrossRef]
  144. Martin-Gallausiaux, C.; Marinelli, L.; Blottière, H.M.; Larraufie, P.; Lapaque, N. SCFA: Mechanisms and Functional Importance in the Gut. Proc. Nutr. Soc. 2021, 80, 37–49. [Google Scholar] [CrossRef]
  145. Slavin, J. Fiber and Prebiotics: Mechanisms and Health Benefits. Nutrients 2013, 5, 1417–1435. [Google Scholar] [CrossRef]
  146. Ueno, K.; Koga, T.; Kato, K.; Golenbock, D.T.; Gendler, S.J.; Kai, H.; Kim, K.C. MUC1 Mucin Is a Negative Regulator of Toll-like Receptor Signaling. Am. J. Respir. Cell Mol. Biol. 2008, 38, 263–268. [Google Scholar] [CrossRef]
  147. Banday, M.Z.; Sameer, A.S.; Nissar, S. Pathophysiology of Diabetes: An Overview. Avicenna J. Med. 2020, 10, 174–188. [Google Scholar] [CrossRef]
  148. Jalili, C.; Moradi, S.; Babaei, A.; Boozari, B.; Asbaghi, O.; Lazaridi, A.V.; Hojjati Kermani, M.A.; Miraghajani, M. Effects of Cynara scolymus L. on Glycemic Indices: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Complement. Ther. Med. 2020; 52, 102496. [Google Scholar]
  149. Fantini, N.; Colombo, G.; Giori, A.; Riva, A.; Morazzoni, P.; Bombardelli, E.; Carai, M.A.M. Evidence of Glycemia-Lowering Effect by a Cynara scolymus L. Extract in Normal and Obese Rats. Phytother. Res. 2011, 25, 463–466. [Google Scholar] [CrossRef]
  150. Meng, S.; Cao, J.; Feng, Q.; Peng, J.; Hu, Y. Roles of Chlorogenic Acid on Regulating Glucose and Lipids Metabolism: A Review. Evid. Based Complement. Altern. Med. 2013, 2013, 11. [Google Scholar] [CrossRef]
  151. Giuntini, E.B.; Sardá, F.A.H.; de Menezes, E.W. The Effects of Soluble Dietary Fibers on Glycemic Response: An Overview and Futures Perspectives. Foods 2022, 11, 3934. [Google Scholar] [CrossRef]
  152. Ahn, H.Y.; Kim, M.; Seo, C.R.; Yoo, H.J.; Lee, S.H.; Lee, J.H. The Effects of Jerusalem Artichoke and Fermented Soybean Powder Mixture Supplementation on Blood Glucose and Oxidative Stress in Subjects with Prediabetes or Newly Diagnosed Type 2 Diabetes. Nutr. Diabetes 2018, 8, 42. [Google Scholar] [CrossRef] [PubMed]
  153. Reynolds, A.N.; Akerman, A.P.; Mann, J. Dietary Fibre and Whole Grains in Diabetes Management: Systematic Review and Meta-Analyses. PLoS Med. 2020, 17, e1003053. [Google Scholar] [CrossRef] [PubMed]
  154. Sanz, M.; Marco del Castillo, A.; Jepsen, S.; Gonzalez-Juanatey, J.R.; D’Aiuto, F.; Bouchard, P.; Chapple, I.; Dietrich, T.; Gotsman, I.; Graziani, F.; et al. Periodontitis and Cardiovascular Diseases: Consensus Report. J. Clin. Periodontol. 2020, 47, 268–288. [Google Scholar] [CrossRef]
  155. Nelson, R.H. Hyperlipidemia as a Risk Factor for Cardiovascular Disease. Prim. Care Clin. Off. Pract. 2013, 40, 195–211. [Google Scholar] [CrossRef]
  156. Amini, M.R.; Sheikhhossein, F.; Alvani, M.; Shoura, S.M.S.; Sohrabnavi, A.; Heidarian, E.; Hekmatdoost, A. Anti-Hypertensive Effects of Artichoke Supplementation in Adults: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Clin. Nutr. Res. 2022, 11, 214–227. [Google Scholar] [CrossRef] [PubMed]
  157. Santos, H.O.; Bueno, A.A.; Mota, J.F. The Effect of Artichoke on Lipid Profile: A Review of Possible Mechanisms of Action. Pharmacol. Res. 2018, 137, 170–178. [Google Scholar] [CrossRef] [PubMed]
  158. Davidson, M.H.; Maki, K.C. Effects of Dietary Inulin on Serum Lipids. J. Nutr. 1999, 129, 1474S–1477S. [Google Scholar] [CrossRef]
  159. Li, H.; Xia, N.; Brausch, I.; Yao, Y.; Förstermann, U. Flavonoids from Artichoke (Cynara scolymus L.) Up-Regulate Endothelial-Type Nitric-Oxide Synthase Gene Expression in Human Endothelial Cells. J. Pharmacol. Exp. Ther. 2004, 310, 926–932. [Google Scholar] [CrossRef]
  160. Dugger, B.N.; Dickson, D.W. Pathology of Neurodegenerative Diseases. Cold Spring Harb. Perspect. Biol. 2017, 9, a028035. [Google Scholar] [CrossRef]
  161. Ransohoff, R.M. How Neuroinflammation Contributes to Neurodegeneration. Science 2016, 353, 777–783. [Google Scholar] [CrossRef]
  162. Guo, S.; Wang, H.; Yin, Y. Microglia Polarization from M1 to M2 in Neurodegenerative Diseases. Front. Aging Neurosci. 2022, 14, 815347. [Google Scholar] [CrossRef] [PubMed]
  163. Vaknine, S.; Soreq, H. Central and Peripheral Anti-Inflammatory Effects of Acetylcholinesterase Inhibitors. Neuropharmacology 2020, 168, 108020. [Google Scholar] [CrossRef]
  164. Zhou, Y.; Zhang, S.; Fan, X. Role of Polyphenols as Antioxidant Supplementation in Ischemic Stroke. Oxid. Med. Cell Longev. 2021, 2021, 5471347. [Google Scholar] [CrossRef]
  165. Číž, M.; Dvořáková, A.; Skočková, V.; Kubala, L. The Role of Dietary Phenolic Compounds in Epigenetic Modulation Involved in Inflammatory Processes. Antioxidants 2020, 9, 691. [Google Scholar] [CrossRef]
  166. Gomez-Pinilla, F.; Tyagi, E. Diet and Cognition: Interplay between Cell Metabolism and Neuronal Plasticity. Curr. Opin. Clin. Nutr. Metab. Care 2013, 16, 726–733. [Google Scholar] [CrossRef]
  167. Lu, C.-W.; Lin, T.-Y.; Hsieh, P.; Chiu, K.-M.; Lee, M.-Y.; Wang, S.-J. Cynarin, a Caffeoylquinic Acid Derivative in Artichoke, Inhibits Exocytotic Glutamate Release from Rat Cortical Nerve Terminals (Synaptosomes). Neurochem. Int. 2023, 167, 105537. [Google Scholar] [CrossRef] [PubMed]
  168. Lewerenz, J.; Maher, P. Chronic Glutamate Toxicity in Neurodegenerative Diseases—What Is the Evidence? Front. Neurosci. 2015, 9, 170294. [Google Scholar] [CrossRef] [PubMed]
  169. Amoriello, T.; Mellara, F.; Ruggeri, S.; Ciorba, R.; Ceccarelli, D.; Ciccoritti, R. Artichoke By-Products Valorization for Phenols-Enriched Fresh Egg Pasta: A Sustainable Food Design Project. Sustainability 2022, 14, 14778. [Google Scholar] [CrossRef]
  170. Canale, M.; Spina, A.; Summo, C.; Strano, M.C.; Bizzini, M.; Allegra, M.; Sanfilippo, R.; Amenta, M.; Pasqualone, A. Waste from Artichoke Processing Industry: Reuse in Bread-Making and Evaluation of the Physico-Chemical Characteristics of the Final Product. Plants 2022, 11, 3409. [Google Scholar] [CrossRef]
  171. Le, T.T.; Vo, A.P.; Thao, V.; Dang, N.; Viet, V.; Le, M. Crackers Fortified with Various Ratios of Cynara scolymus L. Leaf Extract Residue: Nutritional, Physical and Sensory Quality. Chem. Eng. Trans. 2023, 106, 859–864. [Google Scholar] [CrossRef]
  172. Dadalı, C. Artichoke Bracts as Fat and Wheat Flour Replacer in Cake: Optimization of Reduced Fat and Reduced Wheat Flour Cake Formulation. J. Food Meas. Charact. 2023, 17, 98–107. [Google Scholar] [CrossRef]
  173. San José, F.J.; Collado-Fernández, M.; López, R. Sensory Evaluation of Biscuits Enriched with Artichoke Fiber-Rich Powders (Cynara scolymus L.). Food Sci. Nutr. 2018, 6, 160–167. [Google Scholar] [CrossRef]
  174. Abdel-Rahman, A.M.; Ahmed, R.A.-K. Utilization of Artichoke Processing Wastes as Fat Replacer in Beef Sausage. Egypt. J. Food Sci. 2023, 51, 13–31. [Google Scholar] [CrossRef]
  175. Ergezer, H.; Kaya, H.İ.; ŞiMşek, Ö. Antioxidant and Antimicrobial Potential of Artichoke (Cynara scolymus L.) Extract in Beef Patties. Czech J. Food Sci. 2018, 36, 154–162. [Google Scholar] [CrossRef]
  176. Mazzaglia, A.; Licciardello, F.; Aurelio, S.; Muratore, G.; Giovanni, M.; Restuccia, C. Effect of Cynara cardunculus extract on the shelf life of aubergine burgers. Ital. J. Food Sci. 2018, 30, 19–25. [Google Scholar]
  177. Essid, I.; Tajine, S.; Gharbi, S.; Bellagha, S. Use of Pomegranate Peel and Artichoke Leaf Extracts to Improve the Quality of Marinated Sardine (Sardinella aurita) Fillets. J. Food Sci. Technol. 2020, 57, 713–722. [Google Scholar] [CrossRef] [PubMed]
  178. Ehsani, J.; Mohammad Mortazavian, A.; Khomeiri, M.; Ghasem Nejad, A. Effects of artichoke (Cynara scolymus L.) extract addition on microbiological and physico-chemical properties of probiotic yogurt. J. Microbiol. Biotechnol. Food Sci. 2015, 4, 536–541. [Google Scholar] [CrossRef]
  179. Frutos, M.J.; Guilabert-Antón, L.; Tomás-Bellido, A.; Hernández-Herrero, J.A. Effect of Artichoke (Cynara scolymus L.) Fiber on Textural and Sensory Qualities of Wheat Bread. Food Sci. Technol. Int. 2008, 14, 49–55. [Google Scholar] [CrossRef]
  180. Valerga, L.; Quintero-Ruiz, N.A.; Concellón, A.; Puppo, M.C. Artichoke, Eggplant and Tomato Flours as Nutritional Ingredients for Wheat Dough: Hydration Properties. J. Food Sci. Technol. 2020, 57, 1954. [Google Scholar] [CrossRef] [PubMed]
  181. Taşkın, B.; Çelik, B.; Kiyak, S.; Savlak, N.; Kumru, F. New Look at Waste Utilization; Use of Artichoke (Cynara scolymus L.) Leaves in the Production of Functional Crackers. Turk. Tarim. Gida Bilim. Teknol. Derg. 2020, 8, 358–364. [Google Scholar] [CrossRef]
  182. Pasqualone, A.; Punzi, R.; Trani, A.; Summo, C.; Paradiso, V.M.; Caponio, F.; Gambacorta, G. Enrichment of Fresh Pasta with Antioxidant Extracts Obtained from Artichoke Canning By-Products by Ultrasound-Assisted Technology and Quality Characterisation of the End Product. Int. J. Food Sci. Technol. 2017, 52, 2078–2087. [Google Scholar] [CrossRef]
  183. Boude, E.; Elshafei, S.; Ahmed, A.; Elgrwany, L. Utilization of Artichoke And Potato Flours In Bakery Products. J. Home Econ.-Menofia Univ. 2014, 24, 57–70. [Google Scholar] [CrossRef]
  184. Demir, T.; Ağaoğlu, S. Antioxidant, Antimicrobial and Metmyoglobin Reducing Activity of Artichoke (Cynara scolymus) Powder Extract-Added Minced Meat during Frozen Storage. Molecules 2021, 26, 5494. [Google Scholar] [CrossRef]
  185. Iran, J. Chem Chemical Characteristics, and Effect of Inulin Extracted from Artichoke (Cynara scolymus L.) Root on Biochemical Properties of Synbiotic Yogurt at the End of Fermentation. Iran. J. Chem. Chem. Eng. (IJCCE) 2018, 37, 219–230. [Google Scholar]
  186. Llorente, B.E.; Brutti, C.B.; Caffini, N.O. Purification and Characterization of a Milk-Clotting Aspartic Proteinase from Globe Artichoke (Cynara scolymus L.). J. Agric. Food Chem. 2004, 52, 8182–8189. [Google Scholar] [CrossRef] [PubMed]
  187. Abd El-Salam, B.A.E.Y.; Ibrahim, O.A.E.H.; El-Sayed, H.A.E.R. Purification and Characterization of Milk Clotting Enzyme from Artichoke (Cynara cardunculus l.) Flowers as Coagulant on White Soft Cheese. Int. J. Dairy Sci. 2017, 12, 254–265. [Google Scholar] [CrossRef]
  188. Chazarra, S.; Sidrach, L.; López-Molina, D.; Rodríguez-López, J.N. Characterization of the Milk-Clotting Properties of Extracts from Artichoke (Cynara scolymus L.) Flowers. Int. Dairy J. 2007, 17, 1393–1400. [Google Scholar] [CrossRef]
  189. Metwalli, A.A.A.; Al-Askalany, S.A.; Negm, M.S. Utilization of Artichoke Leaves as Healthy Drink. Available online: https://scholar.google.com/scholar?hl=zh-CN&as_sdt=0%2C5&q=UTILIZATION+OF+ARTICHOKE+LEAVES+AS+HEALTHY+DRINK&btnG= (accessed on 24 April 2024).
  190. Schuina, G.L.; Quelhas, J.O.F.; de CASTILHOS, M.B.M.; de CARVALHO, G.B.M.; Del Bianchi, V.L. Alternative Production of Craft Lager Beers Using Artichoke (Cynara scolymus L.) as a Hops Substitute. Food Sci. Technol. 2019, 40, 157–161. [Google Scholar] [CrossRef]
  191. Mirderikvandi, M.; Kiani, A.; Khaldari, M.; Alirezaei, M. Effects of Artichoke (Cynara scolymus L.) Extract on Antioxidant Status in Chicken Thigh Meat. Iran. J. Vet. Med. 2016, 73–81. [Google Scholar] [CrossRef]
  192. Al-Masari, A.I.; Al-Himdany, H.Q. EFFECT OF ADDING ARTICHOKE LEAVES EXTRACTPOWDER (Cynara scolymus L.) TO THE DIET ON THE PRODUCTIVE PERFORMANCE OF BROILERS. Iraqi J. Agric. Sci. 2022, 53, 9–15. [Google Scholar] [CrossRef]
  193. Abdel-Shakur Ali, M.; Marrez, D.; Ali, M.A.; Shallan, M.A.; Meshrf, W.A.; Marrez, D.A. Phenolic Constituents, Antioxidant and Antimicrobial Activities of Globe Artichoke (Cynara scolymus L.) Aqueous Extracts Tropical Journal of Natural Product Research Phenolic Constituents, Antioxidant and Antimicrobial Activities of Globe Artichoke (Cynara scolymus L.) Aqueous Extracts. Trop. J. Nat. Prod. Res. 2021, 5, 1986–1994. [Google Scholar] [CrossRef]
  194. Moselhy, M.A.; Abd-Elhafez, K.A.; El-Kholany, E.A.; Gohar, M.R.; Nasr, N.F. Antimicrobial, Antioxidant and Anticancer Properties of Globe Artichoke and Grape by-Products as a Source of the Bio-Active Phenolic Compounds. Egypt. J. Chem. 2023, 66, 609–624. [Google Scholar] [CrossRef]
  195. Zhu, X.; Zhang, H.; Lo, R.; Lu, Y. Antimicrobial Activities of Cynara scolymus L. Leaf, Head, and Stem Extracts. J. Food Sci. 2005, 70, M149–M152. [Google Scholar] [CrossRef]
  196. Zhu, X.F.; Zhang, H.X.; Lo, R. Antifungal Activity of Cynara scolymus L. Extracts. Fitoterapia 2005, 76, 108–111. [Google Scholar] [CrossRef]
  197. Pereira, C.; Barros, L.; Alves, M.J.; Santos-Buelga, C.; Ferreira, I.C.F.R. Artichoke and Milk Thistle Pills and Syrups as Sources of Phenolic Compounds with Antimicrobial Activity. Food Funct. 2016, 7, 3083–3090. [Google Scholar] [CrossRef]
  198. Papuc, C.; Goran, G.V.; Predescu, C.N.; Nicorescu, V.; Stefan, G. Plant Polyphenols as Antioxidant and Antibacterial Agents for Shelf-Life Extension of Meat and Meat Products: Classification, Structures, Sources, and Action Mechanisms. Compr. Rev. Food Sci. Food Saf. 2017, 16, 1243–1268. [Google Scholar] [CrossRef] [PubMed]
  199. Donadio, G.; Mensitieri, F.; Santoro, V.; Parisi, V.; Bellone, M.L.; De Tommasi, N.; Izzo, V.; Piaz, F.D. Interactions with Microbial Proteins Driving the Antibacterial Activity of Flavonoids. Pharmaceutics 2021, 13, 660. [Google Scholar] [CrossRef] [PubMed]
  200. Chojnacka, K.; Skrzypczak, D.; Izydorczyk, G.; Mikula, K.; Szopa, D.; Witek-Krowiak, A. Antiviral Properties of Polyphenols from Plants. Foods 2021, 10, 2277. [Google Scholar] [CrossRef] [PubMed]
Figure 1. (A) Cultivars of the “Blanca de Tudela” variety in the region of Murcia, Spain; (B) cross-section of an immature artichoke head; (C) mature artichoke inflorescence [7].
Figure 1. (A) Cultivars of the “Blanca de Tudela” variety in the region of Murcia, Spain; (B) cross-section of an immature artichoke head; (C) mature artichoke inflorescence [7].
Applsci 14 04940 g001
Figure 2. Beneficial effects of Cynara scolymus L. ↑ Increase; ↓ decrease.
Figure 2. Beneficial effects of Cynara scolymus L. ↑ Increase; ↓ decrease.
Applsci 14 04940 g002
Table 2. Micronutrients and bioactive compounds of diverse botanical parts of artichoke.
Table 2. Micronutrients and bioactive compounds of diverse botanical parts of artichoke.
Composition HeadLeavesBractsStem
Minerals
Macroelements
K(mg/100 g DW)2160 1506.3 21540 12100 3
Ca(mg/100 g DW)380 1386.9 2310 1290 3
Mg(mg/100 g DW)2001220 2130 180 3
Na(mg/100 g DW)100 1194.4 280 1130 3
Microelements
Zn(mg/100 g DW)3.14 12.1 22.09 14.16 4
Fe(mg/100 g DW)3.69 11.6 24.81 13.1 3
Mn(mg/100 g DW)0.97 10.8 21.46 10.46 3
Cu(mg/100 g DW)0.75 13.6 50.77 10.53 3
Dietary Fiber
Total dietary fiber(g/100 g DW)58.8 631.47 760.35 885.28 9
Insoluble dietary fiber(g/100 g DW)44.5 6-38.51 867.95 9
Soluble dietary fiber(g/100 g DW)14.3 6-21.84 817.33 9
Inulin(g/100 g DW)13.9 107.5 1120.2 1025 10
Celullose(g/100 g DW)18 1215.76 1224.15 1214.87 4
Hemicellulose(g/100 g DW)8.27 127.89 1210.86 1212.05 4
Lignin(g/100 g DW)14.06 1210.78 1215.62 126.43 4
Vitamins
Vitamin A(mg/100 g FW)0.024 130.014 130.016 13-
Vitamin B1(mg/100 g FW)0.071 30.04 130.05 13-
Vitamin B2(mg/100 g FW)0.058 130.033 130.042 13-
Vitamin B6(mg/100 g FW)0.11 130.1 130.1 13-
Vitamin B9(mg/100 g FW)68 1355 1359 13-
Vitamin C(mg/100 g FW)10 145 135.4 13-
Vitamin E(mg/100 g FW)0.25 130.2 130.2 13-
Vitamin K(μg/100 g FW)0.015 130.012 130.012 13-
Phenolic compounds
Hydroxycinnamic acids
1-O-Caffeoylquinic acid(mg/100 g DW)11 15nd 154 1511 15
3-O-Caffeoylquinic acid(mg/100 g DW)87.61 20nd 15nd 15Trace 15
5-O-Caffeoylquinic acid(mg/100 g DW)13 15126 15122 15478 15
4-O-Caffeoylquinic acid(mg/100 g DW)13 15nd 15nd 1510 15
Caffeic acid(mg/100 g DW)59.02 2011.1 12nd 16nd 16
1,3-O-Dicaffeoylquinic acid(mg/100 g DW)4.53 163.6 122.82 167.16 16
3,4-O-Dicaffeoylquinic acid(mg/100 g DW)nd 15nd 1510 151315
3,5-O-Dicaffeoylquinic acid(mg/100 g DW)18 15nd 1511 1531 15
1,5-O-Dicaffeoylquinic acid(mg/100 g DW)361 1530 15244 15760 15
4,5-O-Dicaffeoylquinic acid (mg/100 g DW)Trace 15nd 156 158 15
Flavonoids
Naringenin-7-O-rutinoside(mg/100 g DW)nd 16-5.3 165.48 16
Naringenin-7-O-glucoside(mg/100 g DW)nd 16-nd 16nd 16
Luteolin-7-O-rutinoside(mg/100 g DW)nd1 5237 156 1526 15
Luteolin-7-O-glucuronide(mg/100 g DW)18 15217 1515 1518 15
Luteolin-7-O-malonylglucoside(mg/100 g DW)nd 1587 15nd 1512 15
Luteolin (mg/100 g DW)nd 1523 159 157 15
Apigenin-7-O-rutinoside(mg/100 g DW)nd 15nd 15nd 15nd 15
Apigenin-7-O-glucuronide(mg/100 g DW)20515nd 15285 15nd 15
Apigenin malonylglucoside (mg/100 g DW)20 15nd 1531 15nd 15
Apigenin (mg/100 g DW)5 15nd 1510 15nd 15
Quercitin(mg/100 g DW)0.2 120.6 12-0.2 12
Cyanidin 3,5-diglucoside(mg/100 g DW)0.7 17---
Cyanidin 3-glucoside(mg/100 g DW)10.18 17---
Cyanidin 3,5-malonyldiglucoside(mg/100 g DW)16.41 17---
Cyanidin 3-(3″-malonyl) glucoside(mg/100 g DW)2 17---
Cyanidin 3-(6″-malonyl) glucoside (mg/100 g DW)58.56 17---
ABTS TEAC(mg TE/g DW)-17.47 1814.96 1811.97 18
(μmol TE/g DW)39.24 19-32.7 19-
DPPH(mg TE/g DW)-20.42 1819.49 1817.59 18
(μg/mL)28.2 19-6.42 19-
FRAP(µmol Fe2+/g DW)-195.14 18170.78 18121.5 18
(μmol TE/mL)493.9 19-209.10 19-
Total polyphenols(mg GAE/g DW)19.31 2010.59 1810.73 188.89 18
DW: dry weight; FW: fresh weight; FRAP: ferric-reducing ability of plasma; GAE: gallic acid equivalent; nd: not detected; TE: trolox equivalent. 1 Mean values of heads and bracts from nine genotypes of Italian artichoke [43]; 2 extracts from leaves of the “Green Globe” variety supplied by a Polish company [45]; 3 mean composition of five different Italian cultivars [46]; 4 artichoke floral stems collected during winter season from an Egyptian company [42]; 5 artichoke leaves of the genotype “Violetto di Provenza” cultivated in Italy [47]; 6 artichokes cultivated in Spain [48]; 7 “Green Globe” variety cultivated in April [27]; 8 bracts from the Italian “Violetto di Sicilia” variety [49]; 9 stem by-products from the “Violet d’Hyères” variety [50]; 10 artichokes harvested in Argentina [51]; 11 July-harvested artichokes supplied by six Italian companies [52]; 12 artichokes harvested in June in southern Italy [31]; 13 artichokes collected from Nahia region [14]; 14 artichoke cultivar “Blanca de Tudela” harvested in south-eastern Spain [53]; 15 Italian “Violetto di Sicilia” harvested in April [54]; 16 outer bracts from the “Violetto di Sicilia” genotype [20]; 17 artichoke heads of “Green Globe” variety [55]; 18 “Blanc d’Oran” variety cultivated in Tunisia [56]; 19 “Baladi” variety harvested from February to April [12]; 20 artichoke heads supplied by a Chinese company.
Table 3. Health benefits of different artichoke parts.
Table 3. Health benefits of different artichoke parts.
TypeBotanic PartExperiment DesignResultsRef.
Antioxidant activity
In vitroHeadUtilization of a hydroalcoholic extract of artichoke (0.18–1.44 μg/mL; 1–4 h) on Caco-2 human intestinal cellsInhibition of LDL-C oxidation[87]
In vitroStemApplication of extracts from artichoke stems (1 and 2 mg/mL) in LPS-stimulated human THP-1 macrophages for 1 h↓ ROS[86]
↓ IL-6, CCL2
In vitroLeafArtichoke leaf extract (25, 50 and 100 µg/mL; 24 h) on endothelial cells and monocytes obtained from umbilical cords↓ Oxidized LDL[85]
↓ ROS
In vivoLeafAlloxan-induced diabetic rats treated with artichoke leaf extracts (two doses of 200–400 mg/kg bw) daily for 4 weeks ↑ CAT, SOD and GSH in liver and kidney [88]
↓ α-amylase, TC, TG and LDL-C
In vivoLeafCd-toxicity-induced rats treated with artichoke leaf extract (300 mg/kg bw) daily for 4 weeks ↑ CAT, GSH and GPx in liver and kidney[89]
↓ Liver MDA and liver and kidney SOD
In vivoHeadALD-induced mice treated with an ethanolic extract of artichoke (0.4, 0.8, and 1.6 g/kg bw) for 10 days↑ SOD and GSH levels[90]
↓ MDA
In vivoLeafUrolithiasis-induced rats treated with artichoke leaf extract (125, 250 and 500 mg/kg bw) for 28 days↓ MDA and GSH in kidney[91]
Hepatoprotective action
In vitroHeadApplication of artichoke water extract (100 µM; 24 h) in palmitate-induced insulin resistance HepG2 hepatocytes ↓ Expression of PEPCK and G6Pase[92]
Inhibition of GS phosphorylation
In vitroHeadUtilization of artichoke extract (400–1200 µM; 24 h) on rat hepatocytes and human HepG2 cells exposed to H2O2 ↑ GSH [93]
↓ MDA
In vivoLeafApplication of artichoke leaf extract (1.5 g/kg bw) in paracetamol-induced Sprague–Dawley rats for 14 days↓ ALT and AST[94]
↑ GSH and NO levels
↑ SOD, GST and GR
In vivoLeafUtilization of artichoke leaf extract (300 mg/kg bw) male Wistar rats after hepatic ischemia–reperfusion injury↓ ALT, AST, LDH, ALP and CK[95]
↑ SOD, CAT and GPx
In vivoLeafApplication of hydroethanolic leaf extract of artichoke (300 mg/kg bw; 6 weeks) in rats after induction of toxicity with Pb↓ ALT, AST and ALP[96]
↓ TG, VLDL-C and MDA
Clinical trialHeadType 2 diabetes and NAFLD adults received 300 mg of artichoke extract daily for 16 weeks↓ Serum ALT, AST, GGT and ALP[97]
↑ GPx and SOD levels
Improvement in RHI and Frhi
Clinical trialHeadAdults with NAFLD treated with leaf artichoke extract (six tablets of 2700 mg) daily for 8 weeks↓ Serum ALT and AST[98]
↓ TG and TC
Clinical trialLeafApplication of 600 mg artichoke extract in NAFLD adults for 8 weeks↓ ALT and AST[99]
↓ TG and TC, HDL-C and LDL-C
↓ Total bilirubin, portal vein diameter and liver size
Prebiotic and anti-inflammatory effect
In vitroHeadShort-term colonic fermentation analysis after application of artichoke dry extract using an in vitro gut model ↑ Acetate, propionate and total SCFA production[100]
Lactobacillus spp. levels
In vitroBy-productsSCFA and lactic acid production after in vitro fermentation by human fecal microbiota with artichoke by-products for 72 h↑ Acetate, propionate and total SCFA production[101]
Consumption of 54.6% of substrate by the fecal bacteria
In vitroLeafApplication of artichoke leaf extract on Caco-2 cells (0.001, 0.01 and 0.1 mg/mL; 16 h) after in vitro colonic fermentations↓ IL-1β and TNF-α[102]
↑ Antioxidant capacity
In vivoLeafTNBS-induced CD-1 mice treated with an intraperitoneal administration of artichoke leaf extract once per day for 4 days↓ TNF-α[103]
Absence of significant side effects on the extra-intestinal manifestations related to IBD
In vivoHeadC57BL/6 mice with colitis treated with artichoke pectin used at two doses (40 and 80 mg/kg bw) for 15 days↓ TNF-α and ICAM[104]
↓ IL-1β and IL-6
Clinical trialHeadVery-long-chain inulin extracted from globe artichoke (10 g/d) on healthy adults for 3 weeksBifidobacteria, Lactobacillus and Bacteroides–Prevotella [105]
No differences in fecal SCFA production
Hypoglycemic action
In vivoLeafLeaf aqueous extract (200 and 400 mg/kg bw) on streptozotocin-induced diabetic rats for 21 days↓ Serum glucose[106]
↓ TC, TG, LDL-C and VLDL-C
↓ Plasma MDA
In vivoLeafDry leaf extract (0.2 g extract/kg bw) was given to Wistar diabetic rats for 30 days↓ Serum glucose[107]
↓ TC and TG
↓ Serum fructosamine
In vivoHead and leafHypercholesterolemic and diabetic rats treated with artichoke heart and leaf extract (200, 400 and 600 mg/kg bw) for 4 weeks↓ Serum glucose[18]
↓ TC, LDL-C and TG
Clinical trialHeadOverweight and obese IFG patients treated with two daily oral doses of 500 mg of artichoke extract for 8 weeks↓ Serum glucose and insulin [108]
↓ ADAG and HOMA
↓ LDL-C
Clinical trialHeadOverweight and obese adults with newly detected IFG treated with three daily oral assumptions of film-coated tablets of 200 mg of artichoke extract for 8 weeks↓ FBG and glycosylated hemoglobin[109]
↓ HOMA and ADAG
↓ LDL-C and TC
Clinical trialHeadType 2 diabetic patients treated daily with four wheat cookies containing 6 g of globe artichoke powder for 90 days↓ Serum glucose[110]
↓ TC, TG and LDL-C
↑ HDL
Cardioprotective effect
In vitroLeafHCASMC incubated with a cytokine mixture and treated with an aqueous artichoke leaf extract (1–100 µg/mL; 6 h or 24 h) Inhibition of iNOS induction by artichoke leaf extract [72]
↓ Cytokine-induced iNOS promoter activation and iNOS protein expression
In vitroLeafHepG2 cells incubated with 50–250 µg/mL of artichoke leaf extract for 48 h ↑ Free cholesterol production [111]
↑ Bile acid production
In vivoLeafHFD-fed rats treated with leaf extract at two doses (200–400 mg/kg/bw) daily for 2 months ↓ Serum TC, TG, LDH, ALT, MDA and AOPP[112]
↑ SOD, CAT and GPx
Histological findings showed a cardioprotective effect
↑ Fatty acid oxidation inhibition
In vivoLeafCholesterol-fed rats treated with 150, 300 or 600 mg/kg of leaf extract for 4 weeks↓ TC and oxidized-LDL[113]
↓ IL-1, IL-6, TNFα-, IFN-α and C-reactive protein
In vivoStemDiabetic male albino mice treated with artichoke floral stem extract (250 mg/kg bw) ↓ Serum TC and TG[114]
↓ LDL-C and AIP
In vivoHeadHFD-fed hamsters treated with a 20% fiber by-product from artichoke for 3 weeks↓ Total fat, TC, TG and esterified cholesterol [115]
↑ Fecal excretion of total fat, TG and bile acids
Clinical trialLeafPatients with mild hypertension received 50 and 100 mg of artichoke juice concentrate for 12 weeks↓ SBP[116]
↓ DBP
Clinical trialLeafDaily leaf extract intake (twice a day, 250 mg) in adults with low HDL-cholesterol and mild hypercholesterolemia for 60 days↑ HDL-C and MCP-1 [117]
↓ ApoB/ApoA, total-C/HDL-C ratio and NK response
Clinical trialHeadHypercholesterolemic patients treated with a 500 mg daily intake of dry extract of artichoke and beberis for 2 months ↓ TC and LDL-C[118]
↓ Serum TG
Neuroprotective effect
In vitroHeadArtichoke head extracts were subjected to antioxidant activity tests and AChE neuro-related assay↑ AChE inhibition[119]
↑ Inhibition of TMA-d9 production
In vivoLeafHFD-fed mice treated with artichoke leaf ethanol extract (1600 mg/kg bw) daily for 4 weeks↓ TNF-α, IL-1β, SOD and IL-10 in the striatum[120]
↓ ROS and RSN in hypothalamus, prefrontal cortex and striatum measured by DCFH
↓ NO production hypothalamus, prefrontal cortex and striatum
In vivoLeafAflatoxinB1-treated rats fed with artichoke leaf extract (100 mg/kg bw) for 42 days↓ AChE, MAO and NO[121]
↓ GSH, SOD, GST and GPx
↓ TBARS, XO and UA
In vivoLeafFluoride-induced Nile tilapia treated with artichoke leaf extract (300 mg/kg bw) for 60 days↓ AChE
↓ Severity of disease in histopathological findings[122]
↓ MDA, glucose, cortisol and 8-OHdG levels
In vivoHeadMale rats induced with rotenone and treated with artichoke extract (200 mg/kg bw) for 20 days↑ DA tissue concentration and IL-6[123]
↓ IL-1β, cas-3 and cyt-c
Improvements in open locomotion duration, cataleptic state, balance beam and vertical pole performance
In vivoLeafMethanolic leaf extract supplementation (0.8 and 1.6 g/kg bw) in ameliorating DEN-induced BALB/c mice for 14 days.↓ Cas-3 and Bax levels[124]
↑ Klotho and PPARγ levels
↓ MDA and TOS
AchE: acetylcholinesterase; ADAG: a1C-derived average glucose; AIP: atherogenic index of plasma; ALD: alcoholic liver disease; ALP: alkaline phosphatase; ALT: alanine aminotransferase; AOPP: advanced oxidation protein products; Apo: apolipoprotein; AST: aspartate aminotransferase; bw: body weight; Cas: caspase; CAT: catalase; CCL2: chemokine (C-C motif) ligand 2; CK: creatine kinase; Cyt: cytochrome; DA: dopamine; DBP: diastolic blood pressure; DCFH: oxidized 2,7-dichlorofuorescein; DEN: diethylnitrosamine; FBG: fasting blood glucose; Frhi: framingham reactive hyperemia index; G6Pase: glucose-6-phosphatase; GPx: glutathione peroxidase; GR: glutathione reductase; GS: glycogen synthase; GSH: glutathione; GST: glutathione-S-transferase; H2O2: hydrogen peroxide; HCASMC: human coronary smooth muscle cells; HDL-C: high-density lipoprotein cholesterol; HFD: high-fat diet; HOMA: homeostasis model assessment for insulin resistance; ICAM: intercellular adhesion molecule; IFG: impaired fasting glucose; IFN: type I interferon; iNOS: inducible nitric oxide synthase; IL: interleukin; LDH: lactate dehydrogenase; LDL-C: low-density lipoprotein cholesterol; LPS: lipopolysaccharide; MCP: monocyte chemoattractant protein; MAO: monoamine oxidase; MDA: malondialdehyde; NAFLD: nonalcoholic fatty liver disease; NO: nitric oxide; PPARγ: peroxisome-proliferation-activated receptor γ; RHI: reactive hyperemia index; RSN: reactive nitrogen species; ROS: reactive oxygen species; SBP: siastolic blood pressure; SCFA: short-chain fatty acids; SOD: superoxide dismutase; TBARS: thiobarbituric-acid-reactive substances; TC: total cholesterol; TG: triglycerides; TMA: trimethylamine N-oxide; TNBS: trinitrobenzene sulphonic acid; TNF: tumor necrosis factor; TOS: total oxidant status; PEPCK: phosphoenolpyruvate carboxykinase; UA: uric acid; VLDL-C: very-low-density lipoprotein cholesterol; XO: xanthine oxidase; ↑ Increase; ↓ decrease.
Table 4. Application of artichoke extracts in food products.
Table 4. Application of artichoke extracts in food products.
Food ProductFormulationOutcomesRef.
Bakery and pastry productsPastaAddition of artichoke by-products (bracts and stems) extracted with UAE in traditional Italian fresh egg pasta (10%)Higher TPC in the reformulated pasta and lower TPC loss after cooking[169]
Extended shelf-life
BreadReplacement of durum wheat semolina with flour of artichoke by-products (bracts and stems) in bread (5%, 7.5% and 10%)Visible effects on color, increasing a* and reducing b* and L* [170]
Higher water absorption as extract concentration increased
Lower volume and higher hardness, but no moisture loss in 5 days of storage
CrackersAddition of leaf extract residue from artichoke in crackers (3–12%)Decrease in product thickness and hardness[171]
Higher fiber content
Decrease in overall acceptability
CakeReplacement of fat and wheat flour with artichoke bract powder in cake (20% and 40%)Higher TPC and antioxidant activity[172]
Improvement in sensory properties and texture at optimum utilization ratio (replacement of 31.63% of fat and 16.43% of wheat flour)
CookiesAddition of fiber-rich powders from artichoke by-products (bracts and stems) in cookies (4%)Similar overall acceptability to cookies formulated with CRF[173]
Similar behavior during storage to cookies formulated with the CRF
Darker color than cookies formulated with CRF
Meat and fish productsSausageReplacement of fat with artichoke bracts paste in beef sausages (25, 50% and 100% of fat)Improvement in cooking loss, cooking yield and shrinkage[174]
Similar sensory properties, especially in sample with 25% extract
Lowest microbial count when replacing 100% of fat with extract
PattiesAddition of artichoke by-product extract (external bracts) in beef patties (500 and 1000 ppm)Higher TPC and DPPH values than in the control for 500 and 1000 ppm reformulations[175]
Lower TBARS values than in the control at the end of storage for 500 and 1000 ppm reformulations
Inhibition of the viability of total aerobic psychrophilic bacteria, coliform bacteria and yeast mold
Aubergine burgersAddition of 1% and 3% of artichoke extract in aubergine burgersImprovement in the attributes of off-odor, off-flavor and overall[176]
Observed microbial growth values did not exceed the recommended limit
Lower intensity of color and firmness of the burger with 1% artichoke extract
SardinesIncorporation of 5% of artichoke leaf extract in marinated sardine filetsImprovement in oxidative stability and higher content of polyunsaturated fatty acids[177]
Decrease in total volatile basic nitrogen and trimethylamine during storage
Greater color and appearance scores
Dairy productsYogurtAddition of artichoke leaf extract in probiotic yogurt (0.5%)Higher TPC and antioxidant activity[178]
Faster acidity increase, shorter incubation time and greater final titrable acidity than control yogurts
Decrease in overall consumer acceptability
CheeseReplacement of animal rennet with artichoke head extract (0.3%) in the manufacture of Gouda-type cheeses from bovine milkNo significant differences in chemical parameters of cheese analyzed depending on type of coagulant (bovine or vegetable) [80]
No significant organoleptic differences in cheese depending on type of coagulant
Higher level of casein-degrading products
CRF: commercial reference fiber; TPC: total phenolic content; UAE: ultrasound-assisted extraction.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Ayuso, P.; Quizhpe, J.; Rosell, M.d.l.Á.; Peñalver, R.; Nieto, G. Bioactive Compounds, Health Benefits and Food Applications of Artichoke (Cynara scolymus L.) and Artichoke By-Products: A Review. Appl. Sci. 2024, 14, 4940. https://doi.org/10.3390/app14114940

AMA Style

Ayuso P, Quizhpe J, Rosell MdlÁ, Peñalver R, Nieto G. Bioactive Compounds, Health Benefits and Food Applications of Artichoke (Cynara scolymus L.) and Artichoke By-Products: A Review. Applied Sciences. 2024; 14(11):4940. https://doi.org/10.3390/app14114940

Chicago/Turabian Style

Ayuso, Pablo, Jhazmin Quizhpe, María de los Ángeles Rosell, Rocío Peñalver, and Gema Nieto. 2024. "Bioactive Compounds, Health Benefits and Food Applications of Artichoke (Cynara scolymus L.) and Artichoke By-Products: A Review" Applied Sciences 14, no. 11: 4940. https://doi.org/10.3390/app14114940

APA Style

Ayuso, P., Quizhpe, J., Rosell, M. d. l. Á., Peñalver, R., & Nieto, G. (2024). Bioactive Compounds, Health Benefits and Food Applications of Artichoke (Cynara scolymus L.) and Artichoke By-Products: A Review. Applied Sciences, 14(11), 4940. https://doi.org/10.3390/app14114940

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop